Conference Presentations

1. SV Nadkarni, Trivedi, AB Jain, et al. A trauma service: First of its kind in India. Paper read at All Indian Surgeons Conference, Delhi, India , December 1975.

2. RM Kirby, JA Young, SG Hubcher, GB Cuthberton, AB Jain, P McMaster. Cytological diagnosis of hepatic dysfunction following liver transplantation (poster). British Society of Gastroenterology, Cardiff, September 1986 (Abstract Gut 27:A1265, 1986).

3. RM Kirby, P McMaster, D Clements, SG Hubcher, L Augrisani, WAJ Jurewicz, D Adam, JAC Buckles, AB Jain, E Elias. Post-operative morbidity and mortality of liver transplantation. British Transplantation Society, Birmingham, April 1986.

4. AB Jain, B Gunson, P McMaster. Monitoring of Cyclosporine A in liver transplant patients. Cyclosporine A HPLC Workshop, University of Liverpool, September 1986.

5. AB Jain, P McMaster, D Adu, J Michael. Benefit of cadaveric organ transplantation using Cyclosporine A. Second International Conference on Surgery in the Tropics, Bombay, India, February 1987.

6. AB Jain, B Gunson, JAC Buckles, P McMaster. Liver transplantation: Our experience and results. Second International Conference on Surgery in the Tropics, Bombay, India, February 1987.

7. SN Chatterji (USA), C Kurvila (USA), AB Jain (UK), Motiwala (India) Speaker and Co-Chairman. Symposium on organ transplantation. Second International Conference on Surgery in the Tropics. Bombay, India, February 1987.

8. AB Jain, B Gunson, B McDowell, JAC Buckles, E Elias, P McMaster. Pharmacokinetic studies monitoring Cyclosporine by daily trough levels in liver transplant patients. British Transplantation Society, Belfast, April 1987.

9. AB Jain, CH Young. Transperitoneal approach to upper urinary tract lesions and one-stage bilateral procedure. Midland Urology Club, West Midlands Surgical Society, November 1987.

10. AB Jain, JAC Buckles, AD Barnes, D Adu, J Michael, P MacKintosh, P McMaster. Long-term results of cyclosporine renal transplantation from a single center. The Second International Congress on Cyclosporine. Washington, DC, November 1987.

11. AB Jain, B Gunson, JAC Buckles, B McDowell, A Millis, P McMaster. Is elimination of Cyclosporine in bile dependent on liver graft functions and biliary drainage? The Second International Congress on Cyclosporine. Washington, DC, November 1987.

12. AB Jain, A Awad, D Adu, J Michael, JAC Buckles, P McMaster. Is selective conversion from Cyclosporine to Azathioprine in cadaveric renal transplant better than elective conversion? British Transplantation Society, Newcastle Upon Tyne, April 1989.

13. JJ Fung, S Todo, AB Jain, J McCauley, M Alessiani, C Scotti, TE Starzl. Conversion of liver allograft recipients with Cyclosporine-related complications from Cyclosporine to FK 506. Symposium FK 506 IV Congress of the European Society for Organ Transplantation. Barcelona, Spain, October 31, 1989.

14. S Todo, JJ Fung, AJ Demetris, AB Jain, R Venkataramanan, TE Starzl. Early trials with FK 506 as primary treatment in liver transplantation. Symposium FK 506 IV Congress of the European Society for Organ Transplantation. Barcelona, Spain, October 31, 1989.

15. J McCauley, JJ Fung, AB Jain, S Todo, TE Starzl. The side effects of FK 506 upon renal function after liver transplantation. Symposium FK 506 IV Congress of the European Society for Organ Transplantation. Barcelona, Spain, October 31, 1989.

16. AB Jain, JJ Fung, R Venkataramanan, S Todo, M Alessiani, TE Starzl. FK 506 dosage in human organ transplantation. Symposium FK 506 IV Congress of the European Society for Organ Transplantation. Barcelona, Spain, October 31, 1989.

17. R Shapiro, JJ Fung, AB Jain, P Parks, S Todo, TE Starzl. The side effects of the FK 506 in humans. Symposium FK 506 IV Congress of the European Society for Organ Transplantation, Barcelona, Spain, October 31, 1989.

18. DH Van Thiel, M Iqbal, AB Jain, JJ Fung, S Todo, TE Starzl. Gastroenterology and metabolic problems associated with immunosuppression with either Cyclosporine or FK 506 in liver transplantation. Symposium FK 506 IV Congress for the European Society for Organ Transplantation. Barcelona, Spain, October 31, 1989.

19. L Mieles, S Todo, JJ Fung, AB Jain, H Furukawa, M Susuki, TE Starzl. Oral glucose tolerance test in liver recipients treated with FK 506. Symposium FK 506 IV Congress of the European Society for Organ Transplantation. Barcelona, Spain, October 31, 1989.

20. S Staschak, S Wagner, G Block, DH Van Thiel, AB Jain, JJ Fung, S Todo TE Starzl. A cost comparison of liver transplantation with FK 506 or Cyclosporine as the primary immunosuppressive agent. Symposium FK 506 IV Congress of the European Society for Organ Transplantation. Barcelona, Spain, October 31, 1989.

21. R Venkataramanan, AB Jain, E Cadoff, VS Warty, A Krajack, O Imventarza, S Todo, JJ Fung, TE Starzl. Pharmacokinetics of FK 506 pre-clinical and clinical studies. Symposium FK 506 IV Congress of the European Society for Organ Transplantation. Barcelona, Spain, October 31, 1989.

22. AB Jain, R Venkataramanan, E Cadoff, JJ Fung, S Todo, A Krajack, TE Starzl. Effect of hepatic dysfunction and T-tube clamping of FK 506 pharmacokinetics and trough concentrations. Symposium FK 506 IV Congress of the European Society for Organ Transplantation. Barcelona, Spain, October 31, 1989.

23. AB Jain, GJ Burckart, W Diven, R Venkataramanan, TE Starzl. Cyclosporine measurement by FPIA, PcRIA, and HPLC following liver transplantation. Cyclosporine Therapeutic Drug Monitoring. Hawks Bay, Florida, January 1990.

24. BK Gunson, SR Jones, JAC Buckles, AB Jain, P McMaster. Liver transplantation in Birmingham. Use of Cyclosporine: Clinical correlation with drug monitoring. Cyclosporine Therapeutic Drug Monitoring. Hawks Bay, Florida, January 1990.

25. JJ Fung, S Todo, AJ Demetris, AB Jain, M Alessiani, A Tzakis, TE Starzl. Use of FK 506 in the treatment of chronic liver allograft rejection. American Society of Surgical Transplantation. Chicago, IL, 1990.

26. R. Venkataramanan, AB Jain, VS Warty, K Abu-Elmagd, H Furukawa, O Imventarza, JJ Fung, S Todo, TE Starzl. Pharmacokinetics of FK 506 following oral administration. A comparison of FK 506 and Cyclosporine. XIII International Congress of the Transplantation Society, San Francisco, August 1990.

27. JJ Fung, S Todo, A Tzakis, AJ Demetris, AB Jain, K Abu-Elmagd, M Alessiani, TE Starzl. Conversion of liver allograft recipients from Cyclosporine to FK 506-based immunosuppression: Benefits and pitfalls. XIII International Congress of the Transplantation Society, San Francisco, CA, August 1990.

28. S. Todo, JJ Fung, A Tzakis, AJ Demetris, AB Jain, M Alessiani, S Takaya, TE Starzl. 110 consecutive primary orthotopic liver transplantation under FK 506 in adults. XIII International Congress of the Transplantation Society, San Francisco, CA, August 1990.

29. M. Alessiani, S Kusne, M Martin, AB Jain, K Abu-Elmagd, J Moser, JJ Fung, TE Starzl. Infection in adult liver transplant patients under FK 506 immunosuppression. XIII International Congress of the Transplantation Society, San Francisco, CA, August 1990.

30. J McCauley, S Takaya, JJ Fung, A Tzakis, K Abu-Elmagd, AB Jain, S Todo, TE Starzl. The question of FK 506 nephrotoxicity. XIII International Congress of the Transplantation Society, San Francisco, CA, August 1990.

31. S Kusne, M Martin, R Shapiro, M Jordan, M Alessiani, AB Jain, S Todo, TE Starzl. Early infections in kidney transplant recipients under FK 506. XIII International Congress of the Transplantation Society, San Francisco, CA, August 1990.

32. A Zeevi, G Eiras, C Kaufman, M Alessiani, AJ Demetris, K Abu-Elmagd, AB Jain, V Warty, R Venkataramanan, G Burckart, TE Starzl, S Todo, JJ Fung, R Duquesnoy, XIII International Congress of the Transplantation Society, San Francisco, CA, August 1990.

33. JJ Fung, S Todo, A Tzakis, M Alessiani, K Abu-Elmagd, AB Jain, O Bronsther, M Martin, R Gordon, TE Starzl. Current status on FK 506 in liver transplantation. First Symposium of the International Society for Peri-Operative Care in Liver Transplantation. Pittsburgh, PA, September 1990.

34. M Alessiani, AB Jain, K Abu-Elmagd, S Todo, JJ Fung, TE Starzl. An overview on clinical organ transplantation under FK 506. Proceedings of the 22nd International Course of Transplantation and Clinic Immunology, Lyon, France, May 1990.

35. AB Jain, JJ Fung, S Todo, K Abu-Elmagd, M Alessiani, S Takaya, A Tzakis, TE Starzl. Preliminary results of prospective randomized trial of FK 506 versus Cyclosporine (CyA) in orthotopic liver transplantation. British Transplantation Society, Cambridge, April 1991.

36. M. Alessiani, C Ricordi, JJ Fung, K Abu-Elmagd, Jain AB, C. Scotti, A Pinna, U Cillo, G Carrieri, TE Starzl. USO Clinico Del. FK 506 NEL Trapianto di Fegato 1991.

37. AB Jain, R Venkataramanan, S Todo, JJ Fung, K Abu-Elmagd, M Alessiana, TE Starzl. Intravenous, oral pharmacokinetics and dosing of FK 506 in small bowel transplant patients. Second International Symposium on Small Bowel Transplantation. Toronto, Ontario, Canada, October 1991.

38. J Reyes, K Abu-Elmagd, B Nour, S Kusne, M Green, M Alessiani, AB Jain, JJ Fung, A Tzakis, S Todo, TE Starzl. Infectious complications after human small bowel transplantation. Second International Symposium on Small Bowel Transplantation, Toronto, Ontario, Canada, October 1991.

39. AB Jain, S Todo, JJ Fung, R Day, J Bryant, D Abu-Elmagd, M Alessiani, S Takaya, A Tzakis, VS Warty, R Venkataramanan, TE Starzl. Correlation of episodes of rejections with FK dosage and FK level following primary orthotopic liver transplantation. First International Congress on FK 506. Pittsburgh, PA, August 1991.

40. AB Jain, JJ Fung, A Tzakis, K Abu-Elmagd, S Mehta, M Alessiani, S Todo, J Reyes, VS Warty, R Venkataramanan, TE Starzl. Comparative study of Cyclosporine and FK 506 dosage requirement in adult and pediatric orthotopic liver transplantation. First International Congress on FK 506. Pittsburgh, PA, August 1991.

41. AB Jain, R Venkataramanan, JJ Fung, W Diven, VS Warty, K Abu-Elmagd, S Todo, M Alessiani, TE Starzl. Pharmacokinetics of Cyclosporine and nephrotoxicity in orthotopic liver transplant patients rescued with FK 506. First International Congress on FK 506. Pittsburgh, PA, August 1991.

42. S Wagner, J Depee, I Felser, AB Jain, JJ Fung, TE Starzl, S Staschak. Changes in quality of life following conversion from CyA to FK 506 in orthotopic liver transplant patients. First International Congress on FK 506. Pittsburgh, PA, August 1991.

43. S Takaya, O Bronsther, S Todo, K Abu-Elmagd, AB Jain, M Alessiani, JJ Fung, R Gordon, TE Starzl. Re-transplantation of the liver: A comparison of FK 506 Cyclosporine-treated patients. First International Congress on FK 506. Pittsburgh, PA, August 1991.

44. M Alessiani, S Kusne, J Torre-Cisneros, M Martin, AB Jain, K Abu-Elmagd, S Takaya, U Cillo, S Todo, et al. The incidence of CMV infection during a randomized trial comparing cyclosporine to FK 506 immunosuppression in liver transplantation. First International Congress on FK 506. Pittsburgh, PA, August 1991.

45. S Kusne, JJ Fung, M Alessiani, K Abu-Elmagd, AB Jain, S Takaya, J Torre-Cisneros, et al. The incidence of infections during a randomized trial comparing Cyclosporine to FK 506 immunosuppression in liver transplantation. First International Congress on FK 506. Pittsburgh, PA, August 1991.

46. K Abu-Elmagd, O Bronsther, Y Iwaki, M Kobayashi, A Yagihashi, F Bontempo, JJ Fung, M Alessiani, AB Jain, A Tzakis, S Todo, DH Van Thiele, TE Starzl. Acute hemolytic anemia in liver and bone marrow transplant patients under FK 506 therapy. First International Congress on FK 506. Pittsburgh, PA, August 1991.

47. JJ Fung, R Gordon, S Todo, A Tzakis, AB Jain, K Abu-Elmagd, S Takaya, M Alessiani, R Selby, AJ Demetris, et al. The use of FK 506 in primary liver transplantation. First International Congress on FK 506. Pittsburgh, PA, August 1991.

48. K Abu-Elmagd, JJ Fung, M Alessiani, AB Jain, S Takaya, R Venkataramanan, VS Warty, et al. The strategy of FK 506 therapy in liver transplant patients: The effect of graft function. First International Congress on FK 506. Pittsburgh, PA, August 1991.K Abu-Elmagd, JJ Fung, R Daviam, AB Jain, M Alessiani, S Takaya, R Venkataramanan, VS Warty, W Shannon, A Tzakis, S Todo, TE Starzl. Four-hour versus 24-hour intravenous infusion of FK 506 in primary liver recipients. First International Congress on FK 506. Pittsburgh, PA, August 1991.

49. TL Whiteside, J Wilson, A Zeevi, K Abu-Elmagd, AB Jain, JJ Fung, R Herberman, TE Starzl. Serial monitoring of immunologic function and phenotype of lymphocytes in the blood of transplanted patients randomized to Cyclosporine A or FK 506. First International Congress on FK 506. Pittsburgh, PA, August 1991.

50. R Shapiro, M Jordan, V Scantlebury, JJ Fung, C Jensen, A Tzakis, P Carroll, J McCauley, C Ricordi, S Mitchell, RS Day, AB Jain, Y Iwaki, J Reyes, S Todo, et al. FK 506 in clinical kidney transplantation. First International Congress on FK 506. Pittsburgh, PA, August 1991.

51. S Takaya, O Bronsther, S Todo, K Abu-Elmagd, AB Jain, M Alessiani, JJ Fung, RD Gordon, TE Starzl. Re-transplantation of the liver: A comparison of FK 506 and Cyclosporine-treated patients. First International Congress on FK 506. Pittsburgh, PA, August 1991.

52. J McCauley, R Shapiro, A Tzakis, AB Jain, N Gilboa, M Jordan, C Jensen, D Ellis, TE Starzl. Renal transplantation under FK 506 in patients with previous renal failure due to hemolytic uremic syndrome (HUS). First International Congress on FK 506. Pittsburgh, PA, August 1991.

53. R Venkataramanan, AB Jain, Abu-Elmagd, H Abdallah, VS Warty, S Todo, JJ Fung, TE Starzl. Pharmacokinetics of FK 506 in liver transplant patients. First International Congress on FK 506. Pittsburgh, PA, August 1991.

54. A Zeevi, G Eiras, V Warty, R Venkataramanan, K Abu-Elmagd, M Alessiani, AB Jain, AJ Demetris, S Todo, JJ Fung, TE Starzl, R Duquesnoy. First International Congress on FK 506. Pittsburgh, PA, August 1991.

55. J McCauley, JJ Fung, S Todo, AB Jain, TE Starzl. Renal function in liver transplant patients under FK 506. First International Congress on FK 506. Pittsburgh, PA, August 1991.

56. B Eidelman, K Abu-Elmagd, J Wilson, M Alessiani, AB Jain, S Takaya, S Todo, A Tzakis, DH Van Thiel, TE Starzl. Neurotoxicity of FK 506 in liver and thoracic organ transplant recipients. First International Congress on FK 506. Pittsburgh, PA, August 1991.

57. JJ Fung, K Abu-Elmagd, A Tzakis, M Alessiani, E Bloom, AB Jain, D Przepiorka, J Reyes, C Rosenfield, AJ Demetris, R Gordon, TE Starzl. Treatment of chronic graft-versus-host disease (GVHD) following bone marrow transplantation with FK 506. First International Congress on FK 506. Pittsburgh, PA, August 1991.

58. M Roat, JJ Fung, AB Jain, TE Starzl, R Thoft. FK 506 for the treatment of scleritis, uveitis, keratitis, and hearing loss. A case report of Cogan’s syndrome. First International Congress on FK 506. Pittsburgh, PA, August 1991.

59. B Jegasothy, K Abu-Elmagd, C Ackerman, M Alessiani, AB Jain, A Thomson, S Wagner, JJ Fung, S Todo, DH Van Thiel, TE Starzl. Efficacy of FK 506 in the treatment of pyoderma gangrenosum. First International Congress on FK 506. Pittsburgh, PA, August 1991.

60. AB Jain, K Abu-Elmagd, M Alessiani, JJ Fung, S Todo, S Takaya, R Gordon, A Tzakis, TE Starzl. Side effects of FK 506 compared to Cyclosporine in a prospective randomized trial of orthotopic liver transplantation. First International Congress on FK 506. Pittsburgh, PA, August 1991.

61. J McCauley, JJ Fung AB Jain, S Todo, TE Starzl. Renal function after conversion from Cyclosporine to FK 506 in liver transplant patients. First International Congress on FK 506. Pittsburgh, PA, August 1991.

62. AJ Demetris, JJ Fung, S Todo, AB Jain, S Takaya, M Alessiani, K Abu-Elmagd, DH Van Thiel, TE Starzl. Conversion of liver allograft recipients from Cyclosporine to KF 506 immunosuppressive therapy. First International Congress on FK 506. Pittsburgh, PA, August 1991.

63. M Alessiani, JJ Fung, K Abu-Elmagd, AB Jain, S Takaya, A Tzakis, S Todo, TE Starzl. A prospective randomized trial comparing Cyclosporine versus FK 506 in primary liver transplantation. Proceedings of the 5th International Congress of the European Society of Organ Transplantation. Maastricht, The Netherlands, October 6-10, 1991.

64. M Alessiani, C Ricordi, JJ Fung, K Abu-Elmagd, AB Jain, C Scotti, A Pinna, U Cillo, G Carrieri, G Zetti, TE Starzl. USO Clinico Del—FK 506 Nel Trapianto Di Fegato. In All Trapianto Oggi—Proceedings of the 21st Congress of the Italian Society of Organ Transplantation. Ed. Monduzzi: 611-615, 1991.

65. J McCauley, Y Onodera, H Woods, W Irish, JJ Fung, AB Jain, S Todo, TE Starzl. The renal consequences of orthotopic liver transplant rescue therapy with FK 506: three year’s follow up. American Society of Transplant Physicians 11th Annual Scientific Meeting, 1992.

66. AB Jain, N Jabbour, H Ramos, JJ Fung, TE Starzl, DH Van Thiel. Incidence and severity of liver allograft rejection following institution of Alpha Interferon for treatment of viral hepatitis in liver transplant recipients. 94th Annual Meeting of the American Gastroenterological Association, May 1993, Boston, MA, (Abstract) Gastroenterology 104(4)2, A922, 1993.

67. AB Jain, R Venkataramanan, JJ Fung, VS Warty, A Tzakis, S Todo, TE Starzl. Pregnancy in liver transplant patients under FK 506 regimen. 12th American Society of Transplant Physicians. Houston, TX, May 1993.

68. AB Jain, JJ Fung, S Todo, A Tzakis, R Selby, H Ramos, K Abu-Elmagd, J McCauley, R Venkataramanan, TE Starzl. Three-year follow up of adults receiving primary orthotopic liver transplantation under FK 506. Second Congress of the International Liver Transplantation Society. Toronto, Canada, October 1993.

69. JJ Fung, AB Jain, I Hamad, H Doyle, R Selby, A Tzakis, S Todo, TE Starzl. Long-term effects of FK 506 following conversion from Cyclosporine to FK 506 for chronic rejection in liver transplant recipient. 44th American Association for the Study of Liver Disease. Chicago, IL, November 1993. Abstract: Hepatology 18(4):2, 74A, 1993.

70. AB Jain, R Venkataramanan, J Lever, VS Warty, K Abu-Elmagd, H Furukawa, J Reyes, B Nour, A Arthur, A Tzakis, S Todo, TE Starzl. FK 506 in small bowel transplant recipients: Pharmacokinetics and dosing aspects. Third International Symposium on Small Bowel Transplantation. Paris, France, November 1993.

71. AB Jain, A Tsamandas, AJ Demetris, W Irish, H Ramos, N Jabbour, L Echeverri, DH Van Thiel, TE Starzl, JJ Fung. Interferon Alpha 2B for Non A, Non B, and Non C hepatitis in liver allograft recipients. Clinical and Pathological Outcome. 45th American Association for the Study of Liver Diseases. Chicago, IL, November 11-15, 1994. Abstract: Hepatology 20(4):2, 13A, October 1994.

72. AB Jain, JJ Fung, S Todo, H Ramos, R Selby, W Irish, J Reyes, N Jabbour, R Venkataramanan, TE Starzl. Adult primary orthotopic liver transplantation under FK 506: four-year follow up. 45th American Association for the Study of Liver Diseases. Chicago, IL, November 11-15, 1994. Abstract: Hepatology 20(4):2, 137A, October 1994.

73. AB Jain, A Tsamandas, AJ Demetris, W Irish, R Manez, H Ramos, N Jabbour, L Echeverri, DH Van Thiel, TE Starzl, JJ Fung. Clinical outcome and pathological correlation following Interferon Alpha 2B treatment of recurrent hepatitis B and hepatitis C in orthtopic liver allograft recipients. 45th American Association for the Study of Liver Diseases. Chicago, IL, November 11-15, 1994. Abstract: Hepatology 20(4):2, 130A, October 1994.

74. R Venkataramanan, AB Jain, J Lever, VS Warty, S Mehta, G Burckart, R Shapiro, M Jordan, J Reyes, B Nour, JJ Fung, S Todo, TE Starzl. High dose FK506 requirement in transplant patients. XVth World Congress of the Transplantation Society. Kyoto, Japan, August 28 – September 2, 1994.

75. AB Jain, JJ Fung, S Todo, R Selby, H Ramos, T Gayowski, K Abu-Elmagd, O Bronsther, N Jabbour, A Tzakis, TE Starzl. Conversion from FK 506 to Cyclosporine due to FK 506 toxicity following orthotopic liver transplantation. American Society of Transplant Physicians 13th Annual Scientific Meeting, Chicago, IL, May 16-18, 1994.

76. Bronsther, R Manez, S Kusne, W Irish, W Roland, AB Jain, R Lull, AJ Demetris, TE Starzl. Recurrent or de novo B and C hepatitis influence the development of vanishing bile duct syndrome after liver transplantation. XVth World Congress of the Transplantation Society, Kyoto, Japan, August 28 - September 2, 1994.

77. B Nour, J Reyes, A Tzakis, S Todo, M Green, AB Jain, JJ Fung, TE Starzl. Pediatric primary liver transplantation under FK 506 immunosuppression: Four-years’ experience. XVth World Congress of the Transplantation Society. Kyoto, Japan, August 28 – September 2, 1994.

78. AB Jain, JJ Fung, S Todo, R Selby, W Irish, A Tzakis, K Abu-Elmagd, J Reyes, B Nour, J McMichael, S Mitchell, O Bronsther, et al. One thousand consecutive primary liver transplantations under FK 506: Survival and adverse events. XVth World Congress of the Transplantation Society. Kyoto, Japan , August 28 - September 2, 1994.

79. J McCauley, Y Onodera, H Woods, W Irish, JJ Fung, AB Jain, S Todo, TE Starzl. The renal consequences of orthotopic liver transplant resume therapy with FK 506: Three-year follow up. American Society of Transplant Physicians 13th Annual Scientific Meeting. Chicago, IL, May 16-18, 1994.

80. AB Jain, A Tsamandas, N Jabbour, JJ Fung, J Rakela, TE Starzl, AJ Demetris. Long-term clinical and histopathological impact of Alpha Interferon 2B treatment in liver allograft recipients for recurrent hepatitis C viral Disease. American Association for the Study of Liver Diseases: Liver transplantation for chronic viral hepatitis. Reston, VA, March 1995.

81. AB Jain, JJ Fung, S Todo, R Selby, A Casavilla, N Jabbour, H Doyle, D Kramer, Y Kang, W Irish, S Kusne, TE Starzl. Morbidity other than rejection with primary liver transplantation: 1,000 consecutive cases. American Society of Transplant Physician’s 14th Annual Scientific Meeting. Chicago, IL, May 14-17, 1995.

82. J Reyes, AB Jain, S Todo, M Green, JJ Fung, N Jabbour, TE Starzl. Pediatric primary orthotopic liver transplantation under tacrolimus. First International Liver Transplantation Society and Liver Intensive Care Group Europe. London, United Kingdom, September 27-30, 1995. Abstract: Liver Transplantation and Surgery 1(6): 425, November 1995.

83. J Reyes, AB Jain, S Todo, JJ Fung, M Green, N Jabbour, TE Starzl. Conversion from Cyclosporine to tacrolimus in pediatric liver transplant recipients. First International Liver Transplantation Society and Liver Intensive Care Group Europe. London, United Kingdom, September 27-30, 1995. Abstract: Liver Transplantation and Surgery 1(6):425, November 1995.

84. AB Jain, JJ Fung, I Hamad, S Todo, J Reyes, D Kramer, A Casavilla, J Rakela, AJ Demetris, TE Starzl. Long-term outcome of conversion from Cyclosporine to tacrolimus for chronic liver a llograft rejection: Actual more than five-years’ follow up. First International Liver Transplantation Society and Liver Intensive Care Group Europe. London, United Kingdom, September 27-30, 1995. Abstract: Liver Transplantation and Surgery 1(6):425, November 1995.

85. AB Jain, JJ Fung, I Hamad, S Todo, J Reyes, N Jabbour, D Kramer, A Casavilla, J Rakela, JW Marsh, S Iwatsuki, TE Starzl. Adult primary liver transplantation under tacrolimus: More than five- years’ actual follow up. First International Liver Transplantation Society and Liver Intensive Care Group Europe. London, United Kingdom, September 27-30, 1995. Abstract: Liver Transplantation and Surgery 1(6):425, November 1995.

86. AF Dimartini, AB Jain, JJ Fung, W Irish, J Magill, J Rakela, TE Starzl. Liver transplantation in alcoholic and non-alcoholic cirrhosis: Survival according to UNOS status, sobriety and rehabilitation. The International Liver Transplantation Society and Liver Intensive Care Group Europe. London, United Kingdom, September 27-30, 1995, Abstract: Liver Transplantation and Surgery 1(6):425, November 1995.

87. N Jabbour, AB Zajko, J Reyes, AB Jain, W Irish, J Rakela, JJ Fung. Does trans-jugular intrahepatic portosystemic shunt (TIPS) correct thrombocytopenia associated with liver cirrhosis? The International Liver Transplantation Society and Liver Intensive Care Group Europe. September 27- 30, 1995. London, United Kingdom, September 27-30, 1995. Abstract: Liver Transplantation and Surgery 1(6):425, November 1995.

88. AB Jain, R Venkataramanan, JJ Fung, J Reyes, J Lever, VS Warty, S Todo, TE Starzl. Comparative study of pharmacokinetic profile following intravenous infusion of tacrolimus in pediatric and adult liver transplant recipients. The American Association for the Study of Liver Diseases. Chicago, IL, November 3-7, 1995. Abstract: Hepatology 22(4):2: 143A, October 1995.

89. R Venkataramanan, AB Jain, J Lever, VS Warty, S Mehta, G Burckart, R Shapiro, M Jordan, J Reyes, B Nour, JJ Fung, S Todo, TE Starzl. Pharmacokinetics of tacrolimus in transplant patients. Proceedings of the 4th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, 1995.

90. VS Warty, S Zuckerman, T McKaveney, S Mehta, K Velmar, J Chao, AB Jain, R Venkataramanan. Comparison between whole-blood tacrolimus by Abbott, Inc. and plasma tacrolimus by enzyme-linked immunoassay. Proceedings of the 4th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, 1995.

91. AB Jain. Immunosuppression: Novel agents. Pittsburgh Transplantation Institute Conference 1996. Holiday Inn Select at University Center, Pittsburgh, PA, April 11-13, 1996.

92. J Tabasco-Minguillan, AB Jain, M Naik, K Weber, JJ Fung, W Irish, J Rakela, TE Starzl. Incidence and causes of gastrointestinal bleeding in adults following liver transplantation. 96th Annual Meeting of the American Gastroenterological Association. San Francisco, CA, May 19-22, 1996.

93. AB Jain, R Venkataramanan, J Lever, S Zuckerman, VS Warty, I Hamad, JJ Fung, TE Starzl. Pharmacokinetics of Mycophenolate Mofetil and its potential interaction with tacrolimus. American Society of Transplant Surgeons 22nd Annual Scientific Meeting. Dallas, TX, May 29-31, 1996.

94. AB Jain, L Yee, M Nalesnik, JJ Fung, J Reyes, J Rakela, TE Starzl. De novo non-lymphoid malignancies, following 1000 consecutive liver transplantation under tacrolimus. American Society of Transplant Physicians 15th Annual Meeting. Dallas, TX, May 26-30, 1996.

95. PA Kelly, RF Frye, GJ Burckart, R Venkataramanan, AB Jain, JJ Fung, M Romkes, RA Branch. Tacrolimus dosing in stable liver transplant (OLTx) recipients correlates with phenotypic CYP34A enzyme activity but not leukocyte CYP3A4 in RNA expression. American Society of Transplant Physicians 15th Annual Meeting. Dallas, TX, May 26-30, 1996.

96. AK Singhal, AB Jain, J Martell, JJ Fung, W Irish, S Todo, J Reyes, TE Starzl. Impact of positive crossmatch due to IgG versus IgM antibodies on the outcome of primary liver transplantation under tacrolimus. American Society of Transplant Physicians 15th Annual Meeting. Dallas, TX, May 26-30, 1996.

97. AB Jain, J Reyes, L Mieles, JJ Fung, S Todo, J McMichaels, TE Starzl. Conversion of pediatric liver allograft recipients from Cyclosporine to tacrolimus-based immunosuppression. The 2nd International Congress on Pediatric Transplantation. Paris, France, August 22-24, 1996. Abstract: Pediatric Nephrology 10 C31-C94, 1996.

98. A Khanna, AB Jain, G Ziady, JJ Fung, R Jaffe, L Mieles, TE Starzl, J Reyes. Cardiac changes at autopsy in pediatric liver transplant recipients under tacrolimus. The 2nd International Congress on Pediatric Transplantation. Paris, France, August 22-24, 1996. Abstract: Pediatric Nephrology 10:C31-C94, 1996.

99. J Reyes, J Fricker, L Mieles, E Jovine, AB Jain, S Todo, JJ Fung, H Noyola, TE Starzl. Reversible myocardial hypertrophy after liver and liver-small bowel transplantation in children under Tacrolimus (FK 506) immunosuppression. The 2nd International Congress on Pediatric Transplantation. Paris, France, August 22-24, 1996. Abstract: Pediatric Nephrology 10:C31-C94, 1996.

100. AB Jain, L Mieles, S Todo, JJ Fung, J McMichael, TE Starzl, J Reyes. Primary liver transplantation in children under tacrolimus. The 2nd International Congress on Pediatric Transplantation. Paris, France, August 22-24, 1996. Abstract: Pediatric Nephrology 10:C31-C94, 1996.

101. A Khanna, AB Jain, L Mieles, JJ Fung, S Todo, TE Starzl, J Reyes. Liver re-transplantation in children: Study of 184 cases. The 2nd International Congress on Pediatric Transplantation. Paris, France, August 22-24, 1996. Abstract: Pediatric Nephrology 10:C31-C94, 1996.

102. A Khanna, AB Jain, G Ziady, JJ Fung, AJ Demetris, TE Starzl, D Kramer. Cardiac changes at autopsy in adult liver transplant receipients under tacrolimus. XVI International Congress of the Transplantation Society. Barcelona, Spain, August 25-30, 1996.

103. P Kelly, R Frye, GJ Burckart, R Venkataramanan, AB Jain, JJ Fung, M Romkes, RA Branch. Tacrolimus dosing in stable liver transplant (OLTx) recipients correlates with phenotypic CYP3A4 enzyme activity but not leukocyte CYP3A4 mRN expression. American College of Clinical Pharmacy Annual Meeting, 1996.

104. AB Jain, JJ Fung, S Todo, J Reyes, D Kramer, A Casavilla, J Rakela, S Iwatsuki, TE Starzl. More than six years’ actual follow up: Primary adult liver transplantation under tacrolimus. The 47th American Association for the Study of Liver Disease 1996. Abstract: Hepatology 24(4):181A.

105. AB Jain, JJ Fung, S Todo, J Rakela, AJ Demetris, S Iwatsuki, TE Starzl. More than six years’ actual follow up conversion from Cyclosporine to tacrolimus for chronic liver allograft rejection. The 47th American Association for the Study of Liver Disease 1996. Abstract: Hepatology 24(4):181A.

106. AB Jain, M Gadomski, JJ Fung. Conversion from Cyclosporine to Neoral in stable liver transplant recipients. The 47th American Association for the Study of Liver Disease 1996. Abstract: Hepatology 24(4):181A.

107. AB Jain, JJ Fung, I Hamad, J Rakela, J Demetris, J McMichael, TE Starzl. Prospective randomized trial of tacrolimus and Prednisone versus tacrolimus, Prednisone versus tacrolimus, Prednisone and Mycophenolate Mofetil in primary adult liver transplant recipients. Oral presentation at the Joint American Society of Transplant Physicians 16th and Surgeons 23rd. Chicago, IL, May 1997.

108. AB Jain, A Tsamandas, J Rakela, A Demetris, TE Starzl, JJ Fung. Long-term effect of Interferon Alpha for HCV infection post-liver transplantation: Actual five-to-seven-years’ follow up. American Association for the Study of Liver Disease. Virginia, June 1997.

109. E Molmenti, J Bueno, R Venkataramanan, AB Jain, S Todo, J Reyes. Use of Mycophenolate Mofetil in the pediatric population after liver and intestinal transplantation. 16th American Society of Transplant Physicians. Chicago, IL, May 10-14, 1997.

110. E Molmenti, J Bueno, K Abu-Elmagd, R Venkataramanan, AB Jain, S Todo, JJ Fung, J Reyes. Use of Mycophenolate Mofetil in the pediatric population after intestinal transplantation. Fifth International Symposium of Intestinal Transplantation. Cambridge, United Kingdom, July 30 – August 2, 1997.

111. E Molmenti, J Bueno, R Venkataramanan, JJ Fung, AB Jain, S Todo, J Reyes. Use of Mycophenolate Mofetil in the pediatric population after liver and intestinal transplantation. Fourth Congress of the International Liver Transplantation Society. Seattle, WA, October 15-17, 1997. Abstract: Liver Transplantation and Surgery 3(5):C-78(189), 1997.

112. E Molmenti, J Bueno, T Cacciarelli, B Kosmach, AB Jain, JJ Fung, J Reyes. Adolescent noncompliance following liver transplantation. Fourth Congress of the Liver Transplantation Society. Seattle, WA, October 15-17, 1997. Abstract: Liver Transplantation and Surgery 3(5):C-77 (188), 1997.

113. AB Jain, JJ Fung, I Hamad, J Rakela, J Demetris, J McMichael. Prospective randomized trial of tacrolimus and Prednisone versus tacrolimus, Prednisone and Mycophenolate Mofetil in primary adult liver transplant recipients. Fourth Congress of the Liver Transplantation Society’s Plenary Session. Seattle, WA, October 15-17, 1997. Abstract: Liver Transplantation and Surgery 3(5):C-55(70), 1997.

114. AB Jain, JJ Fung, S Todo, J Reyes, D Kramer, J Rakela, TE Starzl. More than seven years’ actual follow up: Primary adult liver transplantation under tacrolimus. Fourth Congress of the International Liver Transplantation Society. Seattle, WA, October 15-17, 1997. Abstract: Liver Transplantation and Surgery 3(5):C-71(162), 1997.

115. AB Jain, A Singhal, JJ Fung, R Lee, AC Tsamandas, TE Starzl, J Demetris. Chronic rejection following primary adult liver transplantation under tacrolimus. 48th American Association for the Study of Liver Diseases. Chicago, IL, November 7-11, 1997. Abstract: Hepatology 29(4):2; 343-A, 1997. Abstract #859.

116. AB Jain, R Kashyap, B Carr, J Rakela, JJ Fung. Clinical significance of elevated serum alfa-feto protein among patients with end-stage liver disease. 48th American Association for the Study of Liver Diseases. Chicago, IL, November 7-11, 1997. Abstract: Hepatology 29(4):2; 171A, 1997. Abstract #171.

117. AB Jain, JJ Fung, I Hamad, S Zuckerman. Use of Mycophenolate Mofetil for tacrolimus-related chronic nephrotixicity in liver transplantation recipients. 48th American Association for the Study of Liver Diseases. Chicago, IL, November 7-11, 1997. Abstract: Hepatology 29(4)2; 235A, 1997. Abstract #429.

118. AB Jain, J Reyes, R Kashyap, M Nalesnik, T Cacciarelli, J McMichael, S Rohal, T Starzl, JJ Fung. Long-term use of tacrolimus in liver transplant recipients. The First International Congress on Immunosuppression. Orlando, FL, December 10-13, 1997.

119. AB Jain, I Hamad, JJ Fung. Conversion from tacrolimus to Neoral in adult liver transplant patients. The First International Congress on Immunosuppression. Orlando, FL, December 10-13, 1997.

120. AB Jain, JJ Fung, I Hamad, J Demetris, F Dodson, TE Starzl. Adult primary liver transplantation: Prospective randomized trial of tacrolimus and Mycophenolate Mofetil. The First International Congress on Immunosuppression. Orlando, December 10-13, 1997.

121. AB Jain, I Hamad, D Brody, JJ Fung. Use of Neoral for neurological complications following primary adult liver transplantation under tacrolimus. New Dimensions in Transplantation. Florence, Italy, February 16-19, 1998.

122. AB Jain, Mary Gadomski, JJ Fung. A prospective study on conversion from Cyclosporin to Neoral in stable adult liver transplant recipients. New Dimensions in Transplantation. Florence, Italy, February 16-19, 1998.

123. AB Jain, JJ Fung, I Hamad, F Dodson, J Rakela, D Kramer, J McMichael, TE Starzl. Adult primary liver transplantation: Prospective randomized trial of tacrolimus and steroid versus tacrolimus, steroid, and Mycophenolate Mofetil. American Society of Transplant Surgeons 24th Annual Meeting. Chicago, IL, May 13-15, 1998. Abstract: Transplantation 66(6): S2, 1998.

124. AB Jain, JJ Fung, J Reyes, R Kashyap, S Rohal, J Rakela, T Cacciarelli, TE Starzl. Primary liver transplantation under tacrolimus in infants, children, adults and seniors: 1000 consecutive patients from single center with five-to-eight years’ actual follow up. American Society of Transplant Surgeons 24th Annual Meeting. Chicago, IL, May 13-15, 1998. Abstract: Transplantation 66(6):S43(172), 1998.

125. AB Jain, J McCauley, R Kashyap, J Reyes, R Shapiro, JJ Fung. Incidence of end-stage renal failutre amongst long-term survival of primary liver transplant recipients under tacrolimus: adults and children. American Society of Transplant Physicians’ 17th Annual Scientific Meeting, Chicago, IL, May 9-13, 1998.

126. I Hamad, AB Jain, JJ Fung, S Kusne. Cytomegalovirus infection in liver transplant recipients: Detection of early antigenemia in peripheral blood leukocytes and pre-emptive therapy. American Society of Transplant Surgeons’ 19th Annual Scientific Meeting, Chicago, IL, May 9-13, 1998.

127. J Reyes, AB Jain, G Mazarietos, R Kashyap, JJ Fung. Conversion of pediatric liver allograft recipients from Cyclosporine to tacrolimus-based immunosuppression: Four-to-eight years’ follow up. American Society of Transplant Physicians’ 17th Annual Scientific meeting, Chicago, IL, May 9-13, 1998.

128. J Reyes, AB Jain, G Mazariegos, R Kashyap, T Cicciarelli, T Starzl, JJ Fung. Primary liver transplantation in children under tacrolimus: Three-to-eight years’ actual follow up. American Society of Transplant Physicians’ 17th Annual Scientific Meeting, Chicago, IL, May 9-13, 1998.

129. E Molmenti, J Bueno, T Cacciarelly, J DeBlassi, B Kosmach, AB Jain, JJ Fung, G Mazariegos, J Reyes. Noncompliance after pediatric liver transplantation. American Society of Transplantation Physician’s 17th Annual Scientific Meeting, Chicago, IL, May 9-13, 1998.

130. E Molmenti, AB Jain, R Shapiro, F Dodson, E Totsuka, JJ Fung. Kidney transplantation for end-stage renal failure in liver transplant recipients with hepatitis C viral infection. American Society of Transplant Physicians’ 17th Annual Scientific Meeting, Chicago, IL, May 9-13, 1998.

131. J McCauley, F Dodson, AB Jain, J Rakela, S Rohal, P Randhawa, JJ Fung. Hepatitis C-related glomerulonephritis: A growing cause of renal failure after liver transplantation. American Society of Transplant Physicians’ 17th Annual Scientific Meeting, Chicago, IL, May 9-13, 1998.

132. J Reyes, AB Jain, G Mazariegos, R KashyP, JJ Fung. Conversion of pediatric liver allograft recipients from Cyclosporin to tacrolimus-based immunosuppression: Four-to-eight years’ follow up. The 1998 Transplantation Society’s XVII World Congress. Montreal, Canada, July 12-17, 1998.

133. J Reyes, AB Jain, G Mazariegos, R Kashyap, T Cicciarelli, TE Starzl, JJ Fung. Primary liver transplantation in children under tacrolimus: Three-to-eight years’ actual follow up. The 1998 Transplantation Society’s XVII World Congress. Montreal, Canada, July 12-17, 1998.

134. I Dvorchik, TV Cacciarelli, AB Jain, G Mazariegos, JJ Fung, J Reyes. Indications and results of hepatic retransplantation in children receiving primary tacrolimus therapy. The 1998 Transplantation Society’s XVII World Congress. Montreal, Canada, July 12-17, 1998.

135. TV Cacciarelli, I Dvorchik, AB Jain, D Gerber, G Mazariegos, JJ Fung, J Reyes. Pre-transplant risk factors and long-term liver allograft outcomes in children receiving primary tacrolimus therapy. The 1998 Transplantation Society’s XVII World Congress. Montreal, Canada, July 12-17, 1998.

136. J Bueno, E Molmenti, J Bueno, TV Cacciarelli, J DeBlassi, B Kosmach, AB Jain, JJ Fung, G Mazariegos, J Reyes. Noncompliance after pediatric liver transplantation. The 1998 Transplantation Society’s XVII World Congress. Montreal, Canada, July 12-17, 1998.

137. AB Jain, JJ Fung, J Reyes, R Kashyap, S Rohal, J Rakela, TE Starzl. Primary liver transplantation under tacrolimus in infants, children, adults and seniors: 1000 consecutive patients from single center with five-to-eight years’ actual follow up. The 1998 Transplantation Society’s XVII World Congress. Montreal, Canada, July 12-17, 1998.

138. AB Jain, JJ Fung, I Hamad, F Dodson, J Rakela, D Kramer, J McMichael, TE Starzl. Adult primary liver transplantation: Prospective randomized trial of tacrolimus and steroid versus tacrolimus, steroid and Mycophenolate Mofetil. The 1998 Transplantation Society’s XVII World Congress. Montreal, Canada, July 12-17, 1998.

139. E Molmenti, AB Jain, R Shapiro, F Dodson, E Totsuka, JJ Fung. Kidney transplantation for end-stage renal failure in liver transplantation recipients carriers of hepatitis C virus. The 1998 Transplantation Society’s XVII World Congress. Montreal, Canada, July 12-17, 1998.

140. V Donnenberg, D Griffin, G Burckhart, AB Jain, A Donnenberg. P-Glycoprotein (p-gp) is responsible for drug elimination in peripheral T-cells from solid organ and stem cell transplantation recipients. The 1998 Transplantation Society’s XVII World Congress. Montreal, Canada, July 12-17, 1998.

141. E Molmenti, J Bueno, R Venkataramanan, JJ Fung, AB Jain, S Todo, J Reyes. Use of Mycophenolate Mofetil in the pediatric population after liver and intestinal transplantation. Third International Congress on Pediatric Transplantation, 1998. Abstract: Ped Transplantation 174(2) 1998. Abstract # 175.

142. AB Jain. Liver transplantation today. First International Workshop (Neurological Problems and Liver Transplantation). Bologna, Italy, May 8, 1998 .

143. J Reyes, AB Jain, G Mazariegos, R Kashyap, JJ Fung. Conversion of pediatric liver allograft recipients from Cyclosporine in tacrolimus-based immunosuppression: Four-to-eight years’ follow up. The International Congress on Pediatric Transplantation, 1998. Abstract: Ped Transplantation 75(2), 1998. Abstract #177.

144. E Molmenti, J Bueno, T Cacciarelli, B Kosmach, J DeBlass, AB Jain, JJ Fung, G Mazariegos, J Reyes. Noncompliance after pediatric liver transplantation: 2(1);78, 1998. Abstract: Ped Transplantation 78(2), 1998. Abstract #192.

145. J Reyes, AB Jain, G Mazariegos, R Kashyap, T Cacciarelli, TE Starzl, JJ Fung. Primary liver transplantation in children under tacrolimus: Three-to-eight years’ actual follow up. Third International Congress on Pediatric Transplantation. Abstract: Ped Transplantation 2(1); 75, 1998.

146. T Cacciarelli, G Mazariegos, I Dvorchik, AB Jain, JJ Fung, J Reyes. Indications and results of hepatic retransplantation in children receivingprimary tacrolimus therapy. Third International Congress on Pediatric Transplantation: Ped Transplantation 183(2), 1998. Abstract #181.

147. J Barnes, AB Jain, L Ondick, C Hartner, R Kashyap, B Carr, JJ Fung. Clinical significance of elevated serum alpha feto protein among patients with end-stage liver disease. The Seventh Annual International Transplant Nurses Society Symposium and General Assembly. Portland, OR, September 10-12, 1998.

148. N Marino, AB Jain, B Flynn, L Kingery, K Nestler, C Hartner, V Raman, J Lever, JJ Fung. Prospective study of pregnancy following liver transplantation under tacrolimus. The Seventh Annual International Transplant Nurses Society Symposium and General Assembly. Portland, OR, September 10-12, 1998.

149. M Gadomski, AB Jain, L Kingery, K Nestler, C Hartner, JJ Fung. Conversion from Cyclosporine to Neoral in stable adult liver transplant recipients. The Seventh Annual International Transplant Nurses Society Symposium and General Assembly. Portland, OR, September 10-12, 1998.

150. S Rohal, AB Jain, K Iurlano, C Gronsky, C Hartner, J Reyes, R Kashyap, JJ Fung. Primary liver transplantation under tacrolimus in infants, children, adults and seniors: 1000 consecutive cases; mean follow up 76 months. The Seventh Annual International Transplant Nurses Society Symposium and General Assembly. Portland, OR, September 10-12, 1998.

151. K Nestler, AB Jain, I Hamad, C Hartner, JJ Fung. Prospective randomized trial of tacrolimus and steroid versus tacrolimus, steroid and Mycophenolate Mofetil in primary liver transplant. The Seventh Annual International Transplant Nurses Society Symposium and General Assembly. Portland, OR, September 10-12, 1998.

152. C Gronsky, AB Jain, K Iurlano, G Mazariegos, R Kashyap, JJ Fung. Conversion of pediatric liver allograft recipients from Cyclosporin to tacrolimus-based immunosuppression: Four-to-eight years’ follow up. The Seventh Annual International Transplant Nurses Society Symposium and General Assembly. Portland, OR, September 10-12, 1998.

153. K Iurlano, AB Jain, C Gronsky, G Mazariegos, R Kashyap, C Hartner, JJ Fung. Primary liver transplantation in children under tacrolimus: Three-to-eight years’ actual follow up. The Seventh Annual International Transplant Nurses Society Symposium and General Assembly. Portland, OR , September 10-12, 1998.

154. M Zak, AB Jain, B Yelochan, L Kingery, K Nestler, C Hartner, A Youk, JJ Fung. Comparative incidence of de novo nonlymphoid malignancies following liver transplantation under tacrolimus using surveillance pedemiologic end-result data. The Seventh Annual International Transplant Nurses Society Symposium and General Assembly. Portland, OR, September 10-12, 1998.

155. M Funovits, AB Jain, I Hamad, B Yelochan, JJ Fung, K Nestler, C Hartner, S Kusne. Cytomegalovirus infection in liver transplant recipients: Detection of early antigenemia (p-g65) in peripheral blood leukocytes and pre-emptive therapy. The Seventh Annual International Transplant Nurses Society Symposium and General Assembly. Portland, OR, September 10-12, 1998.

156. D Brody, AB Jain, L Kingery, K Nestler, C Hartner, JJ Fung. Use of neural for post-liver transplant neurological complication under tacrolimus. The Seventh Annual International Transplant Nurses Society Symposium and General Assembly. Portland, OR, September 10-12, 1998.

157. A Rafail, AB Jain, L Kingery, K Nestler, C Hartner, J McCauley, R Kashyap, JJ Fung. Incidence of end-stage renal failure amongst long-term survival of primary liver transplant recipients under tacrolimus: adults and children. The Seventh Annual International Transplant Nurses Society Symposium and General Assembly. Portland, OR, September 10-12, 1998.

158. AB Jain, I Hamad, R Kashyap, SN Rishi, D Kramer, J Rakela, JJ Fung. Prospective randomized trial of tacrolimus and steroid versus tacrolimus, steroid versus tacrolimus, steroid and Mycophenolate Mofetil in primary adult liver transplantation. 49th American Association for the Study of Liver Diseases and International Association for the Study of the Liver. Chicago, IL, November 4-10, 1998. Abstract: Hepatology 28(4)2; 221A, 1998. Abstract #233.

159. AB Jain, AK Singhal, J Reyes, J Rakela, JJ Fung. Long-term impact of positive crossmatch due to IgG versus IgM antibodies in primary liver transplantation under tacrolimus. 49th American Association for the Study of Liver diseases and International Association for the Study of the Liver. Chicago, IL, November 4-10, 1998. Abstract: Hepatology 28(4);2,351A, 1998. Abstract #756.

160. AB Jain, J Reyes, R Kashyap, N Rishi, S Rohal, J Rakela, JJ Fung. Primary liver transplant under tacrolimus in infants, children, adults and seniors: 1000 consecutive cases: mean follow up seven years. 49th American Association for the Study of Liver Diseases and International Association for the Study of the Liver. Chicago, IL, November 4-10, 1998. Abstract: Hepatology 28(4);2, 351A, 1998. Abstract #755.

161. J Reyes, AB Jain, G Mazariegos, R Kashyap, JJ Fung. Conversion of pediatric liver allograft recipients from Cyclosporin to tacrolimus-based immunosuppression: Mean seven years’ actual follow up. 49th American Association for the Study of Liver Diseases and International Association for the Study of the Liver. Chicago, IL, November 4-10, 1998. Abstract: Hepatology 28(4);2, 351A, 1998. Abstract #754.

162. J Reyes, AB Jain, G Mazariegos, R Kashyap, T Cacciarelli, N Rishi, JJ Fung. Primary liver transplantation in children under tacrolimus and Cyclosporine: Comparative study. 49th American Association for the Study of Liver Diseases and International Association for the Study of the Liver. Chicago, IL, November 4-10, 1998. Abstract: Hepatology 28(4);2, 351A, 1998. Abstract #753.

163. AB Jain, J Demetris, J Rakela, JJ Fung. Conversion from Cyclosporine to tacrolimus for chronic liver allograft rejection: More than eight years’ actual follow up. 49th American Association for the Study of Liver Diseases and International Association for the Study of the Liver. Chicago, IL, November 4-10, 1998. Abstract: Hepatology 28(4);2, 221A, 1998. Abstract #233.

164. R Venkataramanan, J Ou, S Zuckerman, J Pisupati, AB Jain. Plasma protein bindings of Mycophenolic acid affects its clearance. 49th American Association for the Study of Liver Diseases and International Association for the Study of the Liver. Chicago, IL, November 4-10, 1998. Abstract: Hepatology 28(4);2, 271A, 1998. Abstract #434.

165. AB Jain, A DiMartini, N Rishi, MG Fitzgerald, S Rohal, J Rakela, JJ Fung. Long-term results of liver transplantation for alcoholic-related liver disease under tacrolimus. 49th American Association for the Study of Liver Diseases and International Association for the Study of Liver Diseases. Chicago, IL, November 4-10, 1998. Abstract: Hepatology 28(4)2:350A, 1998. Abstract: #752.

166. AB Jain, I Hamad, R Kashyap, N Rishi, D Kramer, J Rakela, JJ Fung. Prospective randomized trial of tacrolimus and steroids versus tacrolimus, steroids and mycophenolate mofetil in primary adult liver transplantation. 49th American Association for the Study of Liver Diseases and International Association for the Study of Liver Diseases. Chicago, IL, November 4-10, 1998. Abstract: Hepatology 28(4)2:241A, 1998. Abstract: #313.

167. AB Jain, J Reyes, S Rohal, TE Starzl, JJ Fung. 1000 consecutive primary liver transplants under tacrolimus: Story of success and failure with mean follow up of seven years’. 119th American Surgical Association. San Diego, CA, April 1999.

168. M Zak, AB Jain, B Yelochan, L Kingery, K Nestler, CA Youk, JJ Fung. Comparative incidence of de novo nonlymphoid malignancies following liver transplantation under tacrolimus using surveillance epidemiologic end-result data. 2nd International Transplant Coordinator’s Society Meeting, Maastricht, The Netherlands. April 1999.

169. M Funovits, AB Jain, I Hamad, B Yelochan, JJ Fung, K Nestler, C Hartner, S Kusne. Cytomegalovirus infection in liver transplant recipients: Detection of early antigenemia (p-g65) in peripheral blood leukocytes and pre-emptive therapy. 2nd International Transplant Coordinator’s Society Meeting, Maastricht, The Netherlands. April 1999.

170. M Funovits, AB Jain, A DiMartini, N Rishi, MG Fitzgerald, S Rohal, JJ Fung. Long-term results of liver transplantation for alcoholic-related liver disease under tacrolimus. 2nd International Transplant Coordinator’s Society Meeting, Maastricht, The Netherlands. April 1999.

171. D Brody, AB Jain, I Hamad, L Kingery, K Nestler, C Hartner, JJ Fung. Use of neural for post-liver transplant neurological complication under tacrolimus. 2nd International Transplant Coordinator’s Society Meeting, Maastricht, The Netherlands. April 1999.

172. A Rafail, AB Jain, L Kingery, K Nestler, C Hartner, J McCauley, R Kashyap, JJ Fung. Incidence of end-stage renal failure amongst long-term survival of primary liver transplant recipients under tacrolimus: Adults and children. M Funovits, AB Jain, I Hamad, B Yelochan, JJ Fung, K Nestler, C Hartner, S Kusne. Cytomegalovirus infection in liver transplant recipients: Detection of early antigenemia (p-g65) in peripheral blood leukocytes and pre-emptive therapy. International Transplant Coordinator’s Society Meeting, Maastricht, The Netherlands. April 1999.

173. D Brody, AB Jain, I Hamad, S Rohal, K Nestler, C Hartner, JJ Fung. Prospective randomized trial of tacrolimus and steroid versus tacrolimus, steroid and Mycophenolate Mofetil in primary liver transplant. M Funovits, AB Jain, I Hamad, B Yelochan, JJ Fung, K Nestler, C Hartner, S Kusne. Cytomegalovirus infection in liver transplant recipients: Detection of early antigenemia (p-g65) in peripheral blood leukocytes and pre-emptive therapy. International Transplant Coordinator’s Society Meeting, Maastricht, The Netherlands. April 1999.

174. B Yelochan, AB Jain, M Funovits, K Nestler, C Hartner, JJ Fung. Conversion from Cyclosporine to tacrolimus for chronic liver allograft rejection: More than eight years’ actual follow up. M Funovits, AB Jain, I Hamad, B Yelochan, JJ Fung, K Nestler, C Hartner, S Kusne. Cytomegalovirus infection in liver transplant recipients: Detection of early antigenemia (p-g65) in peripheral blood leukocytes and pre-emptive therapy. International Transplant Coordinator’s Society Meeting, Maastricht, The Netherlands. April 1999

175. A Rafail, AB Jain, AK Singhal, L Kingery, K Nestler, JJFung. Long-term impact of positive crossmatch due to IgG versus IgM antibodies in primary liver transplantation under tacrolimus in adults and children. M Funovits, AB Jain, I Hamad, B Yelochan, JJ Fung, K Nestler, C Hartner, S Kusne. Cytomegalovirus infection in liver transplant recipients: Detection of early antigenemia (p-g65) in peripheral blood leukocytes and pre-emptive therapy. International Transplant Coordinator’s Society Meeting, Maastricht, The Netherlands. April 1999.

176. S Rohal, AB Jain, K Iurlano, C Gronsky, K Nestler, J Reyes, JJ Fung. Primary liver transplant under tacrolimus: 1000 consecutive cases: mean follow up seven years’.

177. N Marino, AB Jain, L Kingery, K Nestler, C Hartner, JJ Fung. Prospective study of pregnancy following liver transplantation under tacrolimus. International Transplant Coordinator’s Society Meeting, Maastricht, The Netherlands. April 1999.

178. J Rogers, AB Jain, M DeVera, B Yelochan, J Rakela, JJ Fung. Long-term outcome of hepatitis C viral infection in primary adult liver transplant recipients compared to non-HCV under tacrolimus. 8th Annual Meeting of the American Society of Transplantation (AST), May 15-19, 1999. Chicago, IL, 1999. Abstract: Transplantation 67(7):S15, 1999.

179. A Doria, AB Jain, I Marino, S Gruttadauria, VL Scott, JJ Fung. Conversion from tacrolimus to Cyclosporine A following primary liver transplantation under tacrolimus. 18th Annual Meeting of the American Society of Transplantation (AST), May 15-19, 1999. Chicago, IL, 1999. Abstract: Transplantation 67(7):S32, 1999.

180. G Burkart, R Frye, R Branch, R Venkataramanan, T McKaveney, R Hammond, C Rosenberg, JJ Fung, AB Jain. Drug metabolism in older OLTx patients: Effects of donor and recipient age. 18th Annual Meeting of the American Society of Transplantation (AST), May 15-19, 1999. Chicago, IL, 1999. Abstract: Transplantation 67(7):S145, 1999.

181. AB Jain, JJ Fung, S Todo, J Rakela, J Demetris, S Iwatsuki, TE Starzl. More than six years’ actual follow up: Conversion from Cyclosporine to tacrolimus for chronic liver allograft rejection. 18th Annual Meeting of the American Society of Transplantation (AST), May 15-19, 1999. Chicago, IL, 1999. Abstract: Transplantation 67(7):S197, 1999.

182. AB Jain, A DiMartini, N Rishi, MG Fitzgerald, S Rohal, J Rakela, JJ Fung. Long-term results of liver transplantation for alcoholic-related liver disease under tacrolimus. 18th Annual Meeting of the American Society of Transplantation (AST), May 15-19, 1999. Chicago, IL, 1999. Abstract: Transplantation 67(7):S765, 1999.

183. AB Jain, AK Singhal, J Reyes, J Rakela, JJ Fung. Long-term impact of positive crossmatch due to IgG versus IgM antibodies in primary liver transplantation under tacrolimus. 18th Annual Meeting of the American Society of Transplantation (AST), May 15-19, 1999. Chicago, IL, 1999. Abstract: Transplantation 67(7):S198, 1999.

184. J McCauley, AB Jain, I Hamad, JJ Fung. Acute renal failure requiring dialysis in liver transplant recipients under tacrolimus, Prednisone versus tacrolimus, Prednisone and Cellcept. 18th Annual Meeting of the American Society of Transplantation (AST), May 15-19, 1999. Chicago, IL, 1999. Abstract: Transplantation 67(7):S201, 1999.

185. M Devera, AB Jain, A Tsamandas, J Rogers, J Rakela, JJ Fung. Long-term effect of Interferon-Alpha for HCV infection in post-liver transplantation: Actual seven-to-nine years’ follow up. 18th Annual Meeting of the American Society of Transplantation (AST), May 15-19, 1999. Chicago, IL, 1999. Abstract: Transplantation 67(7):S201, 1999.

186. AB Jain, G Mazariegos, K Irulano, JJ Fung, J Reyes. Why some children are still on steroid beyond five years’ post-liver transplantation under tacrolimus. 18th Annual Meeting of the American Society of Transplantation (AST), May 15-19, 1999. Chicago, IL, 1999. Ab stract: Transplantation 67(7):S231, 1999.

187. AB Jain, J Reyes, G Mazariegos, T Cacciarelli, R Kashyap, M Nalesnik, S Rohal, JJ Fung. Incidence of post-transplant lymphoproliferative disorder in adults and children: Consecutive 1000 primary liver transplant recipients under tacrolimus. 18th Annual Meeting of the American Society of Transplantation (AST), May 15-19, 1999. Chicago, IL, 1999. Abstract: Transplantation 67(7):S246, 1999.

188. AB Jain, K Blakomer, JJ Fung. Post-transplant lymphoproliferative disorder (PTLD) following adult liver transplantation: Retrospective study of over 4000 patients over 15 years from a single center. 25th Annual Scientific Meeting, The American Society of Transplant Surgeons (ASTS), Chicago, IL, Transplantation 67(9);S587, 1999.

189. JR Madariaga, AB Jain, G Costa, J Reyes, G Mazariegos, SF Dodson, J Rakela, JJ Fung. Hepatic artery complication following primary liver transplantation in adults and children: 1000 consecutive cases under tacrolimus. 25th Annual Scientific Meeting, The American Society of Transplant Surgeons (ASTS), Chicago, IL, Transplantation 67(9);S599, 1999.

190. AB Jain, S Rohal, J Madariaga, K Abu-Elmagd, SF Dodson, J Rakela, JJ Fung. Reasons for long-term steroid use following primary adult liver transplantation under tacrolimus. 25th Annual Scientific Meeting, The American Society of Transplant Surgeons (ASTS), Chicago, IL, Transplantation 67(9);S601, 1999.

191. AB Jain, G Mazariegos, K Iurlano, JJ Fung. J Reyes. Under tacrolimus, why some children are still on steroids beyond five-years post-liver transplantation. Fifth Congress of the International Liver Transplantation Society, Pittsburgh, PA, August 26-28, 1999. Abstract: Liver Transplantation and Surgery. 5(4); C-13, 12A, 1999.

192. AB Jain, S Rohal, J Madariaga, K Abu-Elmagd, SF Dodson, J Rakela, JJ Fung. Reasons for long-term steroid use following primary adult liver transplantation under tacrolimus. Fifth Congress of the International Liver Transplantation Society, Pittsburgh, PA, August 26-28, 1999. Abstract: Liver Transplantation and Surgery. 5(4); C-4, 12B, 1999.

193. AB Jain, JJ Fung, I Hamad, S Zuckerman, D Venkataramanan. Use of Mycophenolate Mofetil for tacrolimus-related chronic nephrotoxicity in liver transplant recipients. Fifth Congress of the International Liver Transplantation Society, Pittsburgh, PA, August 26-28, 1999. Abstract: Liver Transplantation and Surgery. 5(4); C-4, 13, 1999.

194. AB Jain, J Reyes, G Mazariegos, T Cacciarelly, R Kashyap, M Nalesnik, S Rohal, JJ Fung. Post-transplant lymphoproliferative disorder in adults and children: Consecutive 1000 primary liver transplant recipients under tacrolimus. Fifth Congress of the International Liver Transplantation Society, Pittsburgh, PA, August 26-28, 1999. Abstract: Liver Transplantation and Surgery. 5(4); C-, 27A, 1999.

195. AB Jain, K Blakomer, JJ Fung, P Randhawa, SF Dodson, J Rakela, M Nalesnik. Incidence of post-transplant lymphoproliferative disorder (PTLD): Retrospective study of over 4000 adults after liver transplantation 15-years’ experience from a single center. Fifth Congress of the International Liver Transplantation Society, Pittsburgh, PA, August 26-28, 1999. Abstract: Liver Transplantation and Surgery. 5(4); C-8, 27B, 1999.

196. AB Jain, I Hamad, SF Dodson, D Kramer, J Rakela, A Demetris, JJ Fung. Prospective randomized trial of tacrolimus and steroids versus tacrolimus and Mycophenolate Mofetil in primary adult liver transplantation. Fifth Congress of the International Liver Transplantation Society, Pittsburgh, PA, August 26-28, 1999. Abstract: Liver Transplantation and Surgery. 5(4); C-25, 97, 1999.

197. AB Jain, I Hamad, M Funovits, JJ Fung. Detection of early antigenemia (p-g65) in peripheral blood leukocytes and pre-emptive therapy for Cytomegalovirus infection in liver transplant recipients. Fifth Congress of the International Liver Transplantation Society, Pittsburgh, PA, August 26-28, 1999. Abstract: Liver Transplantation and Surgery. 5(4); C-35, 135, 1999.

198. J Reyes, AB Jain, G Mazariegos, R Kashyap, JJ Fung. Conversion of pediatric liver allograft recipients from Cyclosporin to tacrolimus for acute and chronic rejection: mean seven years’ follow up. Fifth Congress of the International Liver Transplantation Society, Pittsburgh, PA, August 26-28, 1999. Abstract: Liver Transplantation and Surgery. 5(4); C-38, 147, 1999.

199. J Reyes, AB Jain, G Mazariegos, R Kashyap, T Cacciarelli, N Rishi, JJ Fung. Comparative study: Primary liver transplantation in children under tacrolimus and Cyclosporine. Fifth Congress of the International Liver Transplantation Society, Pittsburgh, PA, August 26-28, 1999. Abstract: Liver Transplantation and Surgery. 5(4); C-38, 148, 1999.

200. AB Jain,l AK Singhal, J Reyes, J Rakela, JJ Fung. Impact of positive crossmatch due to IgG versus IgM antibodies in primary liver transplantation under tacrolimus in long term. Fifth Congress of the International Liver Transplantation Society, Pittsburgh, PA, August 26-28, 1999. Abstract: Liver Transplantation and Surgery. 5(4); C-26, 99, 1999.

201. G Burckart, R Frye, R Branch, R Venkataramanan, T McKaveney, R Hamond, C Rosenberg, JJ Fung, AB Jain. Drug metabolism in older OLTx patients: Effects of donor and recipient age. Fifth Congress of the International Liver Transplantation Society, Pittsburgh, PA, August 26-28, 1999. Abstract: Liver Transplantation and Surgery. 5(4); C-27, 104, 1999.

202. AB Jain, J Reyes, R kashyap, N Rishi, S Rohal, J Rakela, JJ Fung. Primary liver transplant under tacrolimus in infants, children, adults and seniors: 1000 consecutive cases: Mean follow up seven years’. Fifth Congress of the International Liver Transplantation Society, Pittsburgh, PA, August 26-28, 1999. Abstract: Liver Transplantation and Surgery. 5(4); C-27, 103, 1999.

203. AB Jain, J McCauley, R Kashyap, A Rafail, JJ Fung. End-stage renal failure amongst long-term survival of primary liver transplant recipients under tacrolimus: Adults and children. Fifth Congress of the International Liver Transplantation Society, Pittsburgh, PA, August 26-28, 1999. Abstract: Liver Transplantation and Surgery. 5(4); C-27, 105, 1999.

204. A Doria, AB Jain, I Marino, S Gruttadauria, V Scott, JJ Fung. Conversion from tacrolimus toCyclosporine A following primary liver transplantation under tacrolimus. Fifth Congress of the International Liver Transplantation Society, Pittsburgh, PA, August 26-28, 1999. Abstract: Liver Transplantation and Surgery. 5(4); C-28, 106, 1999.

205. S Agarwal, E Culligan, AB Jain, P Chakrabarti, G Matzke, J McCauley, R Shapiro, G Burckart, M Virji, R Venkataramanan. Assessment of renal function in liver and renal transplant patients. Fifth Congress of the International Liver Transplantation Society, Pittsburgh, PA, August 26-28, 1999. Abstract: Liver Transplantation and Surgery. 5(4); C-28, 107, 1999.

206. J Pisupati, AB Jain, S Zuckerman, I Hamad, J Lever, R Venkatarmanan. Time dependent changes in the kinetics of mycophenolate acid (MPA) in liver transplant patients. Fifth Congress of the International Liver Transplantation Society, Pittsburgh, PA, August 26-28, 1999. Abstract: Liver Transplantation and Surgery. 5(4); C-30, 114, 1999.

207. R Venkataramanan, AB Jain, I Hamad, S Mehta, V Warty, JJ Fung. Mycophenolate Mofetil has no effect on tacrolimus pharmacokinetics in liver transplant patients. Fifth Congress of the International Liver Transplantation Society, Pittsburgh, PA, August 26-28, 1999. Abstract: Liver Transplantation and Surgery. 5(4); C-30, 116, 1999.

208. J Rogers, AB Jain, M DeVera, B Yelochan, J Rakela, JJ Fung. Outcome of hepatitis C viral (HCV) infection in primary adult liver transplant recipients compared to non-HCV under tacrolimus. Fifth Congress of the International Liver Transplantation Society, Pittsburgh, PA, August 26-28, 1999. Abstract: Liver Transplantation and Surgery. 5(4); C-33, 128, 1999.

209. M DeVera, AB Jain, A Tsamandas, J Rakela, JJ Fung. Results of Interferon-Alpha for HCV infection post-liver transplantation: Results after actual five-to-seven years’ follow up. Fifth Congress of the International Liver Transplantation Society, Pittsburgh, PA, August 26-28, 1999. Abstract: Liver Transplantation and Surgery. 5(4); C-33, 129, 1999.

210. AB Jain, JJ Fung, J Reyes, R Venkatarmanan. Comparative study of pharmacokinetic profile following intravenous infusion of tacrolimus in pediatric and adult liver transplant recipients. Fifth Congress of the International Liver Transplantation Society, Pittsburgh, PA, August 26-28, 1999. Abstract: Liver Transplantation and Surgery. 5(4); C-39, 150, 1999.

211. AB Jain, J Madriaga, G Costa, J Reyes, G Mazariegos, SF Dodson, J Rakela, JJ Fung. Rate of hepatic artery complication following primary liver transplantation in adults and children: 1000 consecutive cases under tacrolimus. Fifth Congress of the International Liver Transplantation Society, Pittsburgh, PA, August 26-28, 1999. Abstract: Liver Transplantation and Surgery. 5(4); C-42, 162, 1999.

212. J McCauley, AB Jain, I Hamad, JJ Fung. Post-operative acute renal failure in liver transplant recipients under tacrolimus, Prednisone versus tacrolimus, Prednisone and Cellcept. Fifth Congress of the International Liver Transplantation Society, Pittsburgh, PA, August 26-28, 1999. Abstract: Liver Transplantation and Surgery. 5(4); C-42, 163, 1999.

213. AB Jain, J Demetris, J Rakela, TE Starzl, JJ Fung. Conversion from Cyclosporine to tacrolimus for chronic liver allograft rejection: More than six years’ actual follow up. Fifth Congress of the International Liver Transplantation Society, Pittsburgh, PA, August 26-28, 1999. Abstract: Liver Transplantation and Surgery. 5(4); C-49, 191, 1999.

214. A DiMartini, N Day, M Dew, T Lane, AB Jain. Outcome of liver transplantation in alcoholic cirrhosis. Fifth Congress of the International Liver Transplantation Society, Pittsburgh, PA, August 26-28, 1999. Abstract: Liver Transplantation and Surgery. 5(4); C-51, 198, 1999.

215. R Kashyap, AB Jain, B Carr, J Rakela, J Barnes, JJ Fung. Elevated serum alpha-feto protein among patients with end-stage liver disease and its clinical significance. Fifth Congress of the International Liver Transplantation Society, Pittsburgh, PA, August 26-28, 1999. Abstract: Liver Transplantation and Surgery. 5(4); C-57, 222, 1999.

216. R Venkatarmanan, J Ou, S Zuckerman, J Pisupati, AB Jain. Does plasma protein binding of mycophenolate acid affect its clearance. Fifth Congress of the International Liver Transplantation Society, Pittsburgh, PA, August 26-28, 1999. Abstract: Liver Transplantation and Surgery. 5(4); C-59, 231, 1999.

217. AB Jain, I Hamad, S Zuckerman, J Pisupati, R Venkatarmanan, TE Starzl. The pharmacokinetics of oral tacrolimus in liver transplant patients: Study of intra-individual variation. Fifth Congress of the International Liver Transplantation Society, Pittsburgh, PA, August 26-28, 1999. Abstract: Liver Transplantation and Surgery. 5(4); C-59, 232, 1999.

218. S Agarwal, E Culligan, AB Jain, G Burckart, J McCauley, R Venkataramanan. Assessment of renal function in liver transplant patients. AAPS Annual Meeting in San Francisco, CA, November 1998.

219. S Agarwal, E Culligan, AB Jain, P Chakrabarti, J McCauley, R Shapiro, G Burckart, R Venkataramanan. Evaluation of renal function in renal transplant patients on tacrolimus therapy. USP, May 1999.

220. R Venkataramanan, AB Jain, et al. Pharmacokinetics of tacrolimus not altered by Mycophenolate Mofetil. International Therapeutic Drug Monitoring and Clinical Toxicology Meeting. Calne, Australia, September 1999.

221. R Venkataramanan, AB Jain, et al. Time dependent changes in the kinetics of mycophenolic acid in liver transplant patients. International Therapeutic Drug Monitoring and Clinical Toxicology Meeting, Calne, Austraila, September 1999.

222. J Pisupati, AB Jain, S Zuckerman, I Hamad, J Lever, G Burckart, R Venkataramanan. Time dependent changes in the inetics of mycophenolic acid (MPA) in liver transplant patients. American College of Clinical Pharmacology, Annual Meeting, Washington, DC, 1999.

223. J Pisupati, AB Jain, S Zuckerman, I Hamad, J Lever, G Burckart, R Venkataramanan. Time dependent changes in the kinetics of mycophenolic acid in liver transplant patients. Annual AAPS Meeting. New Orleans, LA, November 1999.

224. S Agarwal, E Culligan, AB Jain, P Chakrabarti, J McCauley, R Shapiro, G Burckart, R Venkataramanan. Evaluation of renal function in renal transplant patients on tacrolimus therapy. Annual AAPS Meeting. New Orleans, LA, November 1999.

225. S Rohal, AB Jain, I Hamad, K Nestler, C Hartner, JJ Fung. Prospective randomized trial of tacrolimus and steroids versus tacrolimus, steroids and Mycophenolate Mofetil in primary adult liver transplantation. The Eighth Annual International Transplant Nurses Society Symposium and General Assembly. Toronto, Canada, September 9-11, 1999.

226. S Rohal, AB Jain, K Nestler, C Hartner, JJ Fung. Reasons for long-term steroid use following primary adult liver transplantation under tacrolimus. The Eighth Annual International Transplant Nurses Society Symposium and General Assembly. Toronto, Canada, September 9-11, 1999.

227. C Gronsy, AB Jain, J Reyes, K Iurlano, G Mazariegos, M Nalesnik, S Rohal, JJ Fung. Post-transplant lymphoproliferative disorder in adults and children: Consecutive 1000 primary liver transplant recipients. The Eighth Annual International Transplant Nurses Society Symposium and General Assembly. Toronto, Canada, September 9-11, 1999.

228. K Iurlano, AB Jain, C Gronsky, G Mazariegos, JJ Fung, J Reyes. Why some children are still on steroids beyond five-years’ post liver transplantation? The Eighth Annual International Transplant Nurses Society Symposium and General Assembly. Toronto, Canada, September 9-11, 1999.

229. A Rafail, M Gadomski, AB Jain, K Nestler, JJ Fung. Conversion from Cyclosporine to tacrolimus for chronic liver allograft rejection: More than six years’ actual follow up. The Eighth Annual International Transplant Nurses Society Symposium and General Assembly. Toronto, Canada, September 9-11, 1999.

230. L Boig, AB Jain, AK Singhal, D Stock, C Shay, A Rafail, S Rohal, JJ Fung. Impact of positive crossmatch due to IgG versus IgM antibodies in primary liver transplantation under tacrolimus in long term. The Eighth Annual International Transplant Nurses Society Symposium and General Assembly. Toronto, Canada, September 9-11, 1999.

231. M Zak, AB Jain, K Blakomer, JJ Fung, K Nestler, C Hartner, M Nalesnik. Post-transplant lymphoproliferative disorder (PTLD) following adult liver transplantation: Retrospective study of over 4000 patients over 15 years’ from a single center. The Eighth Annual International Transplant Nurses Society Symposium and General Assembly. Toronto, Canada, September 9-11, 1999.

232. C Shay, AB Jain, A DiMartini, D Stock, L Boig, S Rohal, JJ Fung. Liver transplantation for alcoholic-related liver disease under tacrolimus: Long-term results. The Eighth Annual International Transplant Nurses Society Symposium and General Assembly. Toronto, Canada, September 9-11, 1999.

233. N Marino, AB Jain, K Nestler, M deVera, JJ Fung. Results of Interferon-Alpha for HCV infection post-liver transplantation: Results after actual five-to-seven years’ follow up. The Eighth Annual International Transplant Nurses Society Symposium and General Assembly. Toronto, Canada, September 9-11, 1999.

234. B Yelochan, M Gadomski, AB Jain, JJ Fung. Use of Mycophenolate Mofetil for tacrolimus-related chronic nephrotoxicity in liver transplantation. The Eighth Annual International Transplant Nurses Society Symposium and General Assembly. Toronto, Canada, September 9-11, 1999.

235. J Flohr, AB Jain, E Molmenti, J Lignoski, D Good, JJ Fung. The Eighth Annual International Transplant Nurses Society Symposium and General Assembly. Toronto, Canada, September 9-11, 1999.

236. AB Jain, K Blakomer, R Kashyap, K Ruppert, S Rohal, TE Starzl, JJ Fung, J Demetris. Does tacrolimus offer virtual freedom from chronic rejection after primary liver transplantation (LTx)? Analysis of 6057 biopsies in 1055 LTx: Mean follow up after six years’. 50th American Association for the Study of Liver Diseases, Dallas, TX, November 5-8, 1999. Abstract: Hepatology 30(4)2, 1999. Abstract #601.

237. AB Jain, JJ Fung, R Kashyap, S Rohal, M Nalesnik. Comparative study of post-transplant lymphoproliferative disorder and de novo cancer after liver transplantation. 50th American Association for the Study of Liver Diseases, Dallas, TX, November 5-8, 1999. Abstract: Hepatology 30(4)2;173, 1999. Abstract #602.

238. AB Jain, K Blakomer, P Randhawa, R Kashyap, JJ Fung, M Nalesnik. Rate of post-transplant lymphoproliferative disorder (PTLD) under Cyclosporine and tacrolimus-based immunosuppression: Review of 4022 adult liver transplant patients. 50th American Association for the Study of Liver Diseases, Dallas, TX, November 5-8, 1999. Abstract: Hepatology 30(4)2, 1999. Abstract #602.

239. J Rogers, AB Jain, M DeVera, J Rakela, JJ Fung. Under tacrolimus’ outcome of hepatitis viral (HCV) infection in primary adult liver transplant recipients compared to non-HCV: Mean follow up of 93 months. 50th American Association for the Study of Liver Diseases, Dallas, TX, November 5-8, 1999. Abstract: Hepatology 30(4)2; 179A, 1999. Abstract #74.

240. AB Jain, K Blakomer, R Kashyap, S Rohal, TE Starzl, JJ Fung, J Demetris. Does tacrolimus offer virtual freedom from chronic rejection after primary liver transplantation (LTx)?: Analysis of 5252 biopsies in 1055 LTx: Mean follow up six years. Fourth International Conference on New Trends in Clinical and Experimental Immunosuppression, Geneva, Switzerland, 1999.

241. AN Vats, R Shapiro, D Ellis, A Gautam, PS Randhawa, M Saxena, V Scantlebury, C Vivas, M Jordan, AB Jain, R Tadikamalla, K Weck. Development of quantitative pcr for BK virus detection in urine and its role in management of allograft viral infection masquerading as acute rejection. First Joint Annual Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation, Chicago, IL, May 13-20, 2000. Abstract: Transplantation 69(8)S136, 2000. Abstract #96.

242. P Chakrabarti, H Wong, A Toyofuki, V Scantlebury, M Jordan, C Vivas, AB Jain, J McCauley, J Johnston, P Randhawa, T Hakala, R Simmons, JJ Fung, TE Starzl. Outcome after steroid withdrawal in adult renal transplant patients receiving tacrolimus-based immunosuppression. First Joint Annual Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation, Chicago, IL, May 13-20, 2000. Chicago, IL, May 13-20. Abstract: Transplantation 69(8)S224, 2000. Abstract #425.

243. AB Jain, J Reyes, G Mazariegos, R Kashyap, R Jaffe, JJ Fung, M Nalesnik. Rate of post-transplant lymphoproliferative disorders (PTLD) in children under Cyclosporine and tacrolimus: 766 Consecutive Recipients: 15 years’ experience. First Joint Annual Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation, Chicago, IL, May 13-20, 2000. Abstract: Transplantation 69(8)317, 2000. Abstract #787.

244. R Kashyap, AB Jain, J Reyes, AJ Demetris, JJ Fung. Causes of re-transplantation, rate and survival after 4000 consecutive primary liver transplantations from a single center with 15 years’ median follow up. First Joint Annual Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation, Chicago, IL, May 13-20, 2000. Abstract: Transplantation 69(8)S320, 2000.

245. R Shapiro, P Randhawa, M Jordan, V Scantlebury, C Vivas, AB Jain, RJ Corry, J McCauley, J Johnston, J Donaldson, E Gray, I Dvorchik, T Hakala, JJ Fung, TE Starzl. An analysis of early renal transplantation protocol biopsies—the high incidence of subclinical acute rejection. Transplant 2000, Chicago, IL, May 13-20. First Joint Annual Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation, Abstract: Transplantation 69(8)S365, 2000.

246. AB Jain, AJ Demetris, R Kashyap, TE Starzl, JJ Fung. Survival patterns after live transplantation: Effect of age, gender, and era in 4000 consecutive patients from a single center with 15-year median follow up. American Surgical Association 120th Annual Meeting. Philadelphia , PA, April 6-8, 2000.

247. G Costa, AB Jain, J Madariaga, J Reyes, G Mazariegos, R Kashyap, JJ Fung. Bile duct complications following liver transplantation in adults and children: 1000 consecutive patients. International Liver Transplantation Society Sixth Congress. Buenos Aires, Argentina, June 23-23, 2000. Abstract: Liver Transplantation 6(3), 2000. Abstract #57.

248. M Giraldo, AB Jain, D Martini, SF Dodson, JJ Fung. Outcome of liver transplantation for hemophiliacs and HCV, with or without HBV and HIV infection under tacrolimus: Nine years’ experience from a single center. International Liver Transplantation Society Sixth Congress. Buenos Aires , Argentina, June 23-23, 2000. Abstract: Liver Transplantation 6(3), 2000. Abstract #94.

249. AB Jain, K Blakomer, R Kashyap, K Ruppert, S Rohal, TE Starzl, JJ Fung, J Demetris. Tacrolimus offers virtual freedom from chronic rejection after primary liver transplantation (LTx): Review of 5252 biopsies in 1055 LTx mean follow up—Six years. International Liver Transplantation Society Sixth Congress. Buenos Aires, Argentina, June 23-23, 2000. Abstract: Liver Transplantation 6(3), 2000. Abstract #105.

250. AB Jain, R Kashyap, J Reyes, AJ Demetris, JJ Fung. Causes of death after liver transplantation (LTx) in 4000 consecutive patients: Median follow up—15-years. International Liver Transplantation Society Sixth Congress. Buenos Aires, Argentina, June 23-23, 2000. Abstract: Liver Transplantation 6(3), 2000. Abstract #110.

251. R Kashyap, AB Jain, J Reyes, AJ Demetris, JJ Fung. Causes of re-transplantation after 4000 consecutive primary liver transplantations from a single center with 15-years’ median follow-up rate and survival. International Liver Transplantation Society Sixth Congress. Buenos Aires, Argentina, June 23-23, 2000. Abstract: Liver Transplantation 6(3), 2000. Abstract #112.

252. AB Jain, JJ Fung, R Kashyap, S Rohal, M Nalesnik. Incidence of de novo cancer and post-transplant lymphoproliferative disorder (PTLD) after liver transplantation under tacrolimus: Comparative study. International Liver Transplantation Society Sixth Congress. Buenos Aires, Argentina, June 23-23, 2000. Abstract: Liver Transplantation 6(3), 2000. Abstract #129.

253. AB Jain, J Reyes, G Mazariegos, R Kashyap, R Jaffe, M Green, JJ Fung, M Nalesnik. Under Cyclosporine and tacrolimus’ rate of post-transplant lymphoproliferative disorders (PTLD) in children: 766 consecutive recipients 15-years’ experience. International Liver Transplantation Society Sixth Congress. Buenos Aires, Argentina, June 23-23, 2000. Abstract: Liver Transplantation 6(3), 2000. Abstract #131.

254. AB Jain, G Mazariegos, R Kashyap, et al. Pediatric liver transplantation in 808 consecutive children: 18-years’ experience from a single center. First Congress of the International Pediatric Transplant Association. Venice, Italy, August 23-25, 2000.

255. AB Jain, J Reyes, G Mazariegos, R Kashyap, et al. Comparison of post-transplant lymphoproliferative disorders (PTLD) in children under Cyclosporine and tacrolimus: 766 consecutive recipients: 15-years’ experience. First Congress of the International Pediatric Transplant Association. Venice, Italy, August 23-25, 2000.

256. R Kashyap, AB Jain, AJ Demetris, SF Dodson, D Kramer, JJ Fung. Rate and causes of re-transplantation with survival after 4000 primary liver transplantations from a single center: Two-to-19 years’ follow up. XVII International Congress of the Transplantation Society. Rome, Italy, August 27 – September 1, 2000.

257. AB Jain, R Kashyap, AJ Demetris, SF Dodson, TE Starzl, JJ Fung. Causes of death after liver transplantation (LTx) in 4000 consecutive patients: Follow up two-to-19 years’. XVII International Congress of the Transplantation Society. Rome, Italy, August 27 – September 1, 2000.AB Jain, R Kashyap, SF Dodson, D Kramer, JJ Fung. Prospective randomized trial of tacrolimus and steroids versus tacrolimus, steroids and mycophenolate mofetil in primary liver transplant: A complete report. XVII International Congress of the Transplantation Society. Rome, Italy, August 27 – September 1, 2000.

258. N Harpur, AB Jain, T Grogan, T Morris, K Emmet, JJ Fung. Incidence of de novo cancer and post-transplant lymphoproliferative disorder (PTLD) after liver transplantation under tacrolimus: Comparative study. Ninth ITNS Symposium and General Assembly. Las Vegas, NE, September 7-10, 2000.

259. D Stock, AB Jain, L Boig, C Shay, JJ Fung. Experience of liver transplantation in patients with human immunodeficiency virus—type I (HIV). Ninth ITNS Symposium and General Assembly. Las Vegas, NE, September 7-10, 2000.

260. C Gronsky, AB Jain, K Iurlano, A Smith, G Mazariegos, JJ Fung. Under Cyclosporine and tacrolimus’ rate of post-transplant lymphoproliferative disorders (PTLD) in children: 766 Consecutive recipients: 15-years’ experience. Ninth ITNS Symposium and General Assembly. Las Vegas, NE, September 7-10, 2000.

261. K Emmett, AB Jain, T Morris, T Grogan, N Harpur, JJ Fung. Prospective randomized trial of tacrolimus and steroids versus tacrolimus, steroids and Mycophenolate Mofetil in primary liver transplantation: A complete report. Ninth ITNS Symposium and General Assembly. Las Vegas, NE, September 7-10, 2000.

262. T Grogan, AB Jain, T Morris, K Emmett, N Harpur, JJ Fung. Survival patterns after liver transplantation: Effect of age, gender, and era in 4000 consecutive patients from a single center with two-to-18 years’ follow up. Ninth ITNS Symposium and General Assembly. Las Vegas, NE, September 7-10, 2000.

263. T Morris, AB Jain, T Grogan, K Emmett, N Harpur, JJ Fung. Causes of re-transplantation after 4000 consecutive primary liver transplantations from a single center with two-to-18 years’ follow up. Ninth ITNS Symposium and General Assembly. Las Vegas, NE, September 7-10, 2000.

264. T Morris, AB Jain, K Emmett, S Rohal, T Grogan, N Harpur, JJ Fung. Does tacrolimus offer virtual freedom from chronic rejection after primary liver transplantation (LTx)? Analysis of 5252 biopsies in 1048 LTx—Mean follow up: Six years. Ninth ITNS Symposium and General Assembly. Las Vegas, NE, September 7-10, 2000.

265. AB Jain, R Kashyap, S Potdar, JJ Fung. Question of steroid withdrawal under tacrolimus for primary biliary cirrhosis (PBC), primary sclerosing cholangitis (PSC) and autoimmune hepatitis (AIH) after liver transplantation and long-term survival. Transplant 2001--The Second Joint American Transplant Meeting, Chicago, IL, May 12-16, 2001.

266. AB Jain, V Scantlebury, V Garrido, P Chakrabarti, R Shapiro, RJ Corry. Use of Rapamycin in pancreatic transplantation under tacrolimus-based immunosuppression. Transplant 2001--The Second Joint American Transplant Meeting, Chicago, IL, May 12-16, 2001.

267. AB Jain, R Kashyap, SF Dodson, A Khan, O Shakil, JJ Fung. Need for ribavirin dose adjustment in relation to renal function for treatment of recurrent HCV infection in post liver transplantation. Transplant 2001--The Second Joint American Transplant Meeting, Chicago, IL, May 12-16, 2001.

268. AB Jain, R Kashyap, JJ Fung. Role of Mycophenolate Mofetil (MMF) in liver transplantation (LTx) for HCV-related end-stage liver failure (a prospective randomized trial). Transplant 2001--The Second Joint American Transplant Meeting, Chicago, IL, May 12-16, 2001.

269. AB Jain, G Mazariegos, R Kashyap, C Doria, M Nalesnik, J Reyes. Comparison of post-transplant lymphoproliferative disorders (PTLD) in children under Cyclosporine and tacrolimus: 766 consecutive recipients: 15-years’ experience. Transplant 2001--The Second Joint American Transplant Meeting, Chicago, IL, May 12-16, 2001.

270. AB Jain, R Kashyap, S Potdar, JJ Fung, J Reyes. Pediatric liver transplantation in 808 consecutive children: 18-years’ experience from a single center. Transplant 2001--The Second Joint American Transplant Meeting, Chicago, IL, May 12-16, 2001.

271. J Reyes, AB Jain, G Mazariegos, R Kashyap, K Iurlano, JJ Fung, TE Starzl. Pediatric liver transplantation in 808 consecutive children: 18-years’ experience from a single center. Accepted as poster presentation at the Festschthrift Honoring Thomas E. Starzl, M.D., Ph.D. Pittsburgh, PA, April 27-28, 2001.

272. AB Jain, J Reyes, R Kashyap, J Mazariegos, B Eghtesad, JJ Fung, TE Starzl. Tacrolimus offers virtual freedom from chronic rejection after primary liver transplantation (LTx) in children and adults in long-term follow up. Accepted as poster presentation at the Festschthrift Honoring Thomas E. Starzl, M.D., Ph.D. Pittsburgh, PA, April 27-28, 2001.

273. AB Jain, R Kashyap, SF Dodson, I Hamad, B Eghtesad, JJ Fung. Prospective randomized trial of tacrolimus and steroids versus tacrolimus, steroids and Mycophenolate Mofetil in primary liver transplantation. Accepted as poster presentation at the Festschthrift Honoring Thomas E. Starzl, M.D., Ph.D. Pittsburgh, PA, April 27-28, 2001.

274. AB Jain, G Mazariegos, R Kashyap, JJ Fung, TE Starzl, J Reyes. Absence of chronic rejection under tacrolimus in pediatric liver transplant recipients: Mean follow up of nine years. Accepted as poster at the Seventh International Liver Transplantation Society Meeting ELTA, Berlin, Germany, July 11-13, 2001. Liver Transplantation 7(6)C-47; 2001. Abstract #185.

275. AB Jain, G Mazariegos, R Kashyap, K Iurlano, JJ Fung, J Reyes. Pediatric Liver Transplantation in 808 consecutive children: 18-years’ experience from a single center. Accepted as poster at the Seventh International Liver Transplantation Society Meeting ELTA, Berlin, Germany, July 11-13, 2001. Liver Transplantation 7(6)C-78; 2001. Abstract #312.

276. I Daly, AB Jain, R Kashyap, JJ Fung, J Reyes. Use of Mycophenolate Mofetil (MMF) for chronic rejection in liver allograft under tacrolimus. Accepted as oral presentation. Seventh International Liver Transplantation Society Meeting ELTA, Berlin, Germany, July 11-13, 2001. Liver Transplantation 7(6)C-83; 2001. Abstract #330.

277. R Kashyap, AB Jain, A Demetris, S Kusne, J Fridell, E Asham, JJ Fung. Incidence and outcome of cytomegaloviral (CMV) hepatitis in adult post-liver transplant allograft under tacrolimus. Accepted as oral presentation. Seventh International Liver Transplantation Society Meeting ELTA, Berlin, Germany, July 11-13, 2001. Liver Transplantation 7(6)C-14; 2001. Abstract #54.

278. AB Jain, R Kashyap, B Eghtesad, G Costa, JJ Fung. The question of steroid withdrawal under tacrolimus for primary biliary cirrhosis (PBC), primary sclerosing cholangitis (PSC) and autoimmune hepatitis (AIH) after liver transplantation and long-term survival. Accepted as a poster presentation. Seventh International Liver Transplantation Society Meeting ELTA, Berlin, Germany, July 11-13, 2001. Liver Transplantation 7(6)C-51; 2001. Abstract #228.

279. AB Jain, R Kashyap, B Eghtesad, A Khan, S Obaid, JJ Fung. Need for ribavirin-dose adjustment in relation to renal function for treatment of recurrent HCV infection in post-liver transplant patients. Accepted as a poster presentation. Seventh International Liver Transplantation Society Meeting ELTA, Berlin, Germany, July 11-13, 2001. Liver Transplantation 7(6)C-5; 2001. Abstract #19.

280. AB Jain, R Kashyap, B Eghtesad, A Khan, S Obaid, JJ Fung. Need for ribavirin-dose adjustment in relation to renal function for treatment of recurrent HCV infection in post-liver transplant patients. Accepted as a poster presentation. Seventh International Liver Transplantation Society Meeting ELTA, Berlin, Germany, July 11-13, 2001. Liver Transplantation 7(6)C-33; 2001. Abstract #130.

281. AB Jain, R Kashyap, A Khan, S Obaid, JJ Fung. Need for ribavirin-dose adjustment in relation to renal function for treatment of recurrent HCV infection in post-liver transplant patients. Accepted as a poster presentation. Accepted as a poster presentation. Hepatitis Single Topic Conference: New Therapeutic Strategies for Hepatitis C. Chicago, IL, June 15-16, 2001.

282. L Boig, AB Jain, M Funovits, B Yelochan, N Marino, C Shay, M Gadomski, D Stock, K Nestler, L King, S Rohal, C Hartner, A Rafail, E Kallenborn, K Newell. Rate of post transplant lymphoproliferative disorder under Cyclosporine (CsA) and tacrolimus (TAC) after liver transplantation (LTx) in adults and children. The 3rd Congress of the International Transplant Coordinators Society, Nagoya, Japan, July 22-27, 2001.

283. N Marino, AB Jain, B Yelochan, M Funovits, M Gadomski, B Flynn, K Nestler, L Kingery, S Rohal, C Hartner, A Rafail, E Kallenborn, K Newell. Survival patterns post liver transplantation: Effect of age, general and era in consecutive 4000 patients with median 15 years’ follow up from single center. The 3rd Congress of the International Transplant Coordinators Society, Nagoya, Japan, July 22-27, 2001.

284. B Yelochan, AB Jain, N Marino, M Funovits, M. Gadomski, K Nestler, L Kingery, S Rohal, C Hartner, A Rafail, E Kallenborn, K Newell. Longitudinal follow up after liver transplantation with hepatic C viral infection. The 3rd Congress of the International Transplant Coordinators Society, Nagoya, Japan, July 22-27, 2001.

285. B Yelochan, AB Jain, D Stock, L Boig, C Shay, N Marino, M Funovits, M Gadomski, K Nestler, L Kingery, S Rohal, C Hartner, A Rafail, E Kallenborn, K Newell. Prospective randomized trial of tacrolimus and steroid vs. tacrolimus, steroid and Mycophenolate Mofetil in primary liver transplantation. The 3rd Congress of the International Transplant Coordnators Society, Nagoya, Japan, July 22-27, 2001.

286. L Boig, AB Jain, M Funovits, B Yelochan, N Marino, C Shay, M Gadomski, D Stock, K Nestler, L King, S Rohal, C Hartner, A Rafail, E. Kallenborn, K Newell. Surgical/Nonsurgical, immunological/nonimmunological, early and late complications after primary liver transplantation: An analysis of 1000 consecutive patients with 8-11 years’ follow up. The 3rd Congress of the International Transplant Coordinators Society, Nagoya, Japan, July 22-27, 2001.

287. M Funovits, AB Jain, B Yelochan, N Marino, M Gadomski, B Flynn, K Nestler, L Kingery, S Rohal, C Hartner, A Rafail, E Kallenborn, K Newell. Tacrolimus offers virtual freedom from chronic rejection after primary liver transplantation (LTx) in children and adults in long-term follow up. The 3rd Congress of the International Transplant Coordinators Society, Nagoya, Japan, July 22-27, 2001.

288. M Funovits, AB Jain, B Yelochan, N Marino, M Gadomski, B Flynn, K Nestler, L Kingery, S Rohal, C Hartner, A Rafail, E Kallenborn, K Newell. Incidence and outcome of cytomegaloviral (CMV) hepatitis in adult post liver transplant allograft under tacrolimus. The 3rd Congress of the International Transplant Coordinators Society, Nagoya, Japan, July 22-27, 2001.

289. N Marino, AB Jain, B Yelochan, M Funovits, M Gadomski, B Flynn, K Nestler, L Kingery, S Rohal, C Hartner, A Rafail, E Kallenborn, K Newell. Question of steroid withdrawal under tacrolimus for primary biliary cirrhosis (PBC) primary sclerosing cholangitis (PSC) and autoimmune hepatitis (AIH) after liver transplantation and long-term survival. The 3rd Congress of the International Transplant Coordinators Society, Nagoya, Japan, July 22-27, 2001.

290. D. Stock, AB Jain, L Boig, C. Shay, M. Gadomsky, K. Nestler, L. Kingery, S. Rohal, M. Funovits, C. Hartner, B. Yelochan, A. Rafail, N. Marino, E. Kallenborn, K. Newell. Longitudinal follow up after liver transplantation with hepatic C viral infection. International Transplant Nurses Society, ITNS 10th Anniversary Symposium, Churchill College, Cambridge, England, August 29-September 1, 2001.

291. A Smith, AB Jain, C Gronsky, K Iurlano, G Mazariegos, JJ Fung, J Reyes. Total absence of chronic rejection under tacrolimus in pediatric liver transplant recipient: Mean follow up of nine years. International Transplant Nurses Society, ITNS 10th Anniversary Symposium, Churchill College, Cambridge, England, August 29-September 1, 2001.

292. A Byerly, K Risch, AB Jain, M Pampena, T Morris, B Flynn, ST Grogan, K Emmett, N Harpur, JJ Fung. Role of Mycophenolate Mofetil (MMF) in Liver Transplantation (LTx) for HCV-related end-stage liver failure (a prospective, randomized trial). International Transplant Nurses Society, ITNS 10th Anniversary Symposium, Churchill College, Cambridge, England, August 29-September 1, 2001.

293. M Gadomsky, K Nestler, AB Jain, L Kingery, S Rohal, M Funovits, C Hartner, B Yelochan, A Rafail, N Marino, M Zak, JJ Fung. Use of Rituximab (Chimeric Anti CD20 Antibody) in post transplant lymphoproliferative disorder after liver, kidney, and pancreas transplantation. International Transplant Nurses Society, ITNS 10th Anniversary Symposium, Churchill College, Cambridge, England, August 29-September 1, 2001.

294. K Risch, A Byerly, AB Jain, M Pampena, T Morris, B. Flynn, ST Grogan, K Emmett, N Harpur, JJ Fung. Incidence and outcome of cytomegaloviral (CMV) hepatitis in adult post liver transplant allograft under tacrolimus. International Transplant Nurses Society, ITNS 10th Anniversary Symposium, Churchill College, Cambridge, England, August 29-September 1, 2001.

295. K Nestler, AB Jain, B Flynn, S Rohal, M Gadomski, L Kingery, M Funovits, C Hartner, B Yelochan, A Rafail, N Marino, E Kallenborn, K Newell. Need for Ribovirin dose adjustment in relation to renal function for treatment of recurrent HCV infection in post liver transplant patients. International Transplant Nurses Society, ITNS 10th Anniversary Symposium, Churchill College, Cambridge, England, August 29-September 1, 2001.

296. AB Jain, R Kashyap, I Hamad, B Eghtesad, S Potdar, A Khan, JJ Fung. Prospective randomized trial of tacrolimus and steroids versus tacrolimus, steroids and Mycophenolate Mofetil in primary liver transplantation. Accepted as a poster presentation. Tenth ESOT Congress 2001. Lisbon, Portugal, October 6-11, 2001.

297. AB Jain, R Kashyap, J Robers, S Obaid, A Khan, JJ Fung. Longitudinal follow up after liver transplantation (LTx) with hepatitis C viral infection. Accepted as an oral presentation. Tenth ESOT Congress 2001. Lisbon, Portugal, October 6-11, 2001.

298. AB Jain, J Reyes, R Kashyap, B Eghtesad, S Potdar, JJ Fung. Tacrolimus offers virtual freedom from chronic rejection after primary liver transplantation (LTx) in children and adults in long-term follow up. Accepted as an oral presentation. Tenth ESOT Congress 2001. Lisbon, Portugal, October 6-11, 2001.

299. AB Jain, R Venkataramanan, R Kashyap, S Rohal, JJ Fung. Profound interaction between tacrolimus and protease inhibitor drugs in liver transplant patients (LTx). Accepted as an oral presentation. Tenth ESOT Congress 2001. Lisbon, Portugal, October 6-11, 2001.

300. AB Jain, J Reyes, R Kashyap, G Mazariegos, M Nalesnik, JJ Fung. Rate of post-transplant lymphoproliferative disorder under Cyclosporin (CsA) and tacrolimus (TAC) after liver transplantation (LTx) in adults and children. Accepted as a poster presentation. Tenth ESOT Congress 2001. Lisbon, Portugal, October 6-11, 2001.

301. AB Jain, K Abu-Elmagd, R Kashyap, JW Marsh, V Scantlebury, RJ Corry, P Fontes, M Nalesnik, JJ Fung. Use of Rituximab (Chimeric anti-CD20 antibody) in post-transplant lymphoproliferative disorder (PTLD) after liver, kidney and pancreas transplantation. Accepted as poster presentation. Tenth ESOT Congress 2001. Lisbon, Portugal, October 6-11, 2001

302. A.B. Jain, G. Mazariegos, Randeep S. Kashyap, John J. Fung, Thomas E. Starzl, Jorge Reyes. Tacrolimus offers total absence of chronic rejection in pediatric liver transplant recipient: Follow up of 7-10 years. The Liver Meeting 2001, The American Association for the Study of Liver Diseases 52nd Annual Meeting, Dallas, Texas, November 9-13, 2001. Hepatology 34(4):2, 2001, p. 246A. Abstract #292.

303. A.B. Jain, Randeep S. Kashyap, K. Abu-Elmagd, P. A. Fontes, J.J. Fung, M. Nalesnik. Use of Rituximab (chimeric anti CD20 antibody) in post transplant lymphoproliferative disorder (PTLD) after liver transplantation. The Liver Meeting 2001, The American Association for the Study of Liver Diseases 52nd Annual Meeting, Dallas, Texas, November 9-13, 2001. Hepatology 34(4):2, p. 285A, 2001. Abstract #452.

304. R.S. Kashyap, A.B. Jain, J.J. Fung. Impact of cytomegaloviral (CMV) hepatitis in adult post liver transplant allograft under tacrolimus. The Liver Meeting 2001, The American Association for the Study of Liver Diseases 52nd Annual Meeting, Dallas, Texas, November 9-13, 2001. Hepatology 34(4):2, p. 285A, 2001. Abstract #453.

305. AB Jain, R.S. Kashyap, B. Eghtesad, S. Obaid, V. Ramesh, K. Akhtar, J.J. Fung. Ribavirin Dose Adjustment in relation to renal function is mandatory for treatment of recurrent HCV infection in post liver transplant patients. The Liver Meeting 2001, The American Association for the Study of Liver Diseases 52nd Annual Meeting, Dallas, Texas, November 9-13, 2001. Hepatology 34(4):2 p. 409A, 2001. Abstract #947.

306. AB Jain, G Mazariegos, RS Kashyap, JJ Fung, J Reyes. Pediatric Liver Transplantation in 808 Consecutive children: 20 Years’ Experience from a Single Center. The 2nd International Congress on Immunosuppression, San Diego, CA, December 6-8, 2001.

307. AB Jain, RS Kashyap, B Eghtesad, PA Fontes, M Gadomski, M Nalesnik, JJ Fung. Use of Rituximab (Chimeric Anti-CD20 Antibody) in Post-Transplant Lymphoproliferative Disorder (PTLD) After Liver Transplantation (LTx). The 2nd International Congress on Immunosuppression, San Diego, CA, December 6-8, 2001.

308. AB Jain, RS Kashyap, B Eghtesad, E Asham, JJ Fung. Role of Mycophenolate Mofetil (MMF) in Liver Transplantation (LTx) for HCV-Related End-Stage Liver Failure (A Prospective Randomised Trial. The 2nd International Congress on Immunosuppression, San Diego, CA, December 6-8, 2001.

309. R Shapiro, MC Jordan, VP Scantlebury, C Vivas, AB Jain, P Randhawa, J McCauley, JR Johnston, S Fedorek, E Gray, I Dvorchak, J Donaldson, JJ Fung, TE Starzl. A Pilot Trial of Tacrolimus and Sirolimus in Renal Transplantation. The 2nd International Congress on Immunosuppression, San Diego, CA, December 6-8, 2001.

310. I Daly, AB Jain, RS Kashyap, JJ Fung. Use of Mycophenolate Mofetil (MMF) for Chronic Rejection in Liver Allograft Under Tacrolimus. The 2nd International Congress on Immunosuppression, San Diego, CA, December 6-8, 2001.AB Jain, G. Mazariegos, RS Kashyap, JJ Fung, TE Starzl, J Reyes. Absence of Chronic Rejection Under Tacrolimus in Pediatric Liver Transplant Recipients: Mean Follow Up of Nine Years. The 2nd International Congress on Immunosuppression, San Diego, CA, December 6-8, 2001.

311. AB Jain, RS Kashyap, B Eghtesad, J Fridell, JJ Fung. Question of Steroid Withdrawal Under Tacrolimus for Primary Biliary Cirrhosis (PBC), Primary Sclerosing Cholangitis (PSC) and Autoimmune Hepatitis (AIH) After Liver Transplantation and Long-Term Survival. The 2nd International Congress on Immunosuppression, San Diego, CA, December 6-8, 2001.

312. AB Jain, R Venkataramanan, JJ Fung. Profound Interaction Between Tacrolimus Anti-HIV Drugs in L